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CHAPTER I 
 
INTRODUCTION 
 
The relationship between diabetes and hearing loss has been postulated since case 
studies reported by Jorado (1857) and Edgar (1915).  Subsequent research has attempted 
to delineate the pathophysiology, clinical manifestation, and covariates involved.  Yet, 
the relationship between diabetes and hearing loss still remains a matter of controversy.  
The root of this controversy generally can be traced to study design, specifically 
population variables and methodology of assessing hearing.  These factors will be 
addressed in discussions that follow. Taylor and Irwin (1978), Fowler and Jones (1999), 
and Maia and Campos (2005) provide excellent reviews of the literature for their 
respective eras. 
The proposed pathological mechanisms contributing to hearing loss in persons 
with type-1 diabetes include: localized microangiopathy in the inner ear, neuronal 
degeneration, and compromised stress response and metabolic function (all with potential 
underlying genetic influences).  These pathological changes and metabolic disturbances 
may contribute to cochlear, retrocochlear, and combined hearing disorders.  However, the 
underlying cellular and molecular mechanisms contributing to hearing loss remain vague.  
A review of proposed mechanisms underlying type-1 diabetes and hearing loss is 
provided as an appendix (see Appendix A). 
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Rationale 
The rationale for this dissertation was to address the lack of a comprehensive 
study of auditory function in young adults with type-1 diabetes with consideration of 
variables that may exacerbate their risk for hearing loss (e.g., noise exposure).  The need 
for this study was based on two prominent features of a thorough literature review.   
First, the literature review demonstrated inconsistent and contradictory findings 
for all auditory function outcomes commonly used in the clinic. The sources of these 
inconsistencies are primarily related to study design problems, specifically population 
variables (no use of matched controls) and methodologies for assessing hearing (lacked 
sensitive metrics or had inappropriate methods) (see chapter specific literature reviews).  
Thus, we sought to perform a comprehensive study, utilizing the most sensitive metrics 
available (using evidence-based methods), and incorporating an age- sex-matched control 
group.    
Second, recent epidemiological findings reported by Bainbridge et al. (2008) and 
others have demonstrated reduced auditory function in participants with diabetes, 
particularly at younger ages (< 40 years of age).  They also reported the differences in 
auditory function compared to controls diminished with age.  This finding was attributed 
to competing factors associated with presbycusis in the control group that narrowed the 
gap between groups and masked the contribution from diabetes.  The demonstration of 
hearing loss in this younger diabetes group questions the hypothesized influence of 
diabetes related complications (e.g., neuropathy and micronangiopathy) that interact with 
the aging process and result in accelerated age-related hearing loss.  While this may be a 
factor, we hypothesized that the early onset of hearing loss demonstrated in these 
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epidemiological studies might be related to exacerbated risk for noise related hearing loss 
(NRHL). 
To appropriately address these questions we have selected a young adult age 
group (18 to 28 years of age).  This age group was selected for the following reasons: (a) 
the age range limits the confounds associated with aging and hearing loss (presbycusis), 
(b) they are young enough for potential early intervention of exacerbating effects of 
covariates (e.g., noise exposure), (c) the group tends to have relatively high noise 
exposure, and (d) are old enough to sit quietly for testing.   
In addition, we implemented the most sensitive metrics of auditory function 
available to examine hearing sensitivity, cochlear function, and neural function.  The 
objectives were to determine if type-1 diabetes is associated with changes in auditory 
function and the sensitivity of our methods in identifying early signs of auditory 
pathology. 
 
Purpose  
The primary goal of this dissertation research is to perform an in-depth 
examination of auditory function (cochlear and peripheral neural [efferent and afferent]) 
in young adults with type-1 diabetes (referred to as experimental group) as compared to 
age- and gender-matched control participants (referred to as control group). Secondary 
objectives include: (a) evaluating covariates associated with auditory function and 
diabetes, with an exploration of increased susceptibility to noise-related pathology in 
persons with type-1 diabetes and (b) assessing the application of auditory function 
measures performed to identify early signs of sensorineural pathology.  
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Specific Aims 
 
 Specific Aim 1.  Characterize auditory function in young adults with type-1 
diabetes using physiologic methods sensitive to subtle changes in cochlear and neural 
function in comparison to a matched control group.  Previous studies relating auditory 
function in patients with diabetes have shown mixed results with some studies noting 
differences and others not.  These differences are likely related to sensitivity of the 
measures used (discussed further in chapter specific literature reviews).  Underlying 
Hypothesis: The experimental group will demonstrate comparable basic audiological 
outcomes (e.g., pure-tone thresholds 250-8000 Hz), but demonstrate significantly poorer 
function compared to the control group on more sensitive measures of cochlear function 
and peripheral auditory neural integrity (e.g., otoacoustic emissions).  Expected Findings: 
The experimental group is expected to have normal pure-tone thresholds, but 
significantly reduced or abnormal cochlear hair cell responses and significantly altered 
peripheral auditory neural function.   
Specific Aim 2.  Determine relationships and influence of covariates (age, sex, 
diabetes related variable) on auditory function in the experimental group.  Underlying 
Hypothesis: Age, sex, and diabetes related variables (duration, HbA1c, control, and 
complications) influence auditory function.  Expected Findings: We do not expect an 
interaction of age with auditory function due to the young age of our sample.  However, 
we do expect sex-related differences in auditory function, particularly in cochlear and 
afferent neural function in both the control and experimental groups.  We expect analyses 
of diabetes related variables in relation to auditory test outcomes will show significantly 
worse performance on pure tone testing, cochlear, and neural function in experimental 
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participants with “poorer” maintained diabetes compared to participants with “better” 
maintained diabetes and the matched-control group participants.   
 Specific Aim 3. We will explore the effects of noise exposure history on auditory 
function in our experimental and control group.  Risk for noise-related auditory damage 
will be estimated via retrospective questionnaires.  Underlying Hypothesis: Diabetes is 
associated with susceptibility to noise-related hearing loss. Expected Findings: The 
experimental group is expected to demonstrate elevated pure-tone thresholds at 
frequencies associated with noise related hearing loss (3000-16000 Hz) and reduced 
cochlear hair cell and efferent neural function, factors which have been associated with 
noise-related hearing loss (NRHL) in general population studies.  Control and 
experimental groups with greater noise exposure are expected to have worse outcome 
measures.  However, the effect is expected to be greater in the experimental group. 
Due to the large scope of this study an alternative format was chosen to enhance 
readability. The various outcomes assessed and analyzed are divided into chapters that 
each includes sections on Literature Review, Methods, Results, and Discussion.  Chapter 
III addresses the Basic Audiological Test Battery; we then move to subsequent chapters 
that address Cochlear Function, followed by Efferent and Afferent Auditory Neural 
Function, consideration of Covariates, and Noise Exposure.  Each of these chapters 
consists of a separate literature review, purpose, methods, results, and discussion 
corresponding to the respective research questions.  The sectional discussions are 
complemented with an Integrating Discussion (Chapter IX) and proposed Future 
Directions (Chapter X). 
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CHAPTER II 
 
OVERVIEW OF METHODS AND  
PARTICIPANT CHARACTERISTICS  
 
Overview of Methods 
 
The scope of this study includes measures of hearing sensitivity (pure-tone 
thresholds 250-16000 Hz), middle ear function (tympanometry and middle-ear muscle 
reflexes), cochlear mechanics (otoacoustic emissions), and peripheral auditory afferent 
and efferent neural function (auditory brainstem responses and otoacoustic emission 
suppression, respectively). In addition, retrospective medical and noise exposure histories 
were obtained.  Participants were recruited from the Vanderbilt University campus, 
Vanderbilt Eskind Diabetes Clinic, and the Vanderbilt Kennedy Center subject 
recruitment website.   
 
Participant Inclusion Criteria 
 
Participant inclusion criteria included ages 18-28 years, normal to near-normal 
hearing (< 35 dB HL at 250-8000 Hz, no air-bone gap > 10 dB HL), normal middle ear 
function (static compliance > .3 ml, normal ear canal volume, and middle ear pressure ± 
100 daPa; ASHA, 1990), non-smoker, and no use of aspirin (within 48 hrs) or significant 
exposure to other ototoxic drugs.  
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Power Analysis 
 
A power analysis was performed to determine the required sample size.  The 
analysis was based on the effect size data from two similar studies that evaluated 
otoacoustic emissions (TEOAE & DPOAE) in young adults with type-1 diabetes 
compared to controls (Ottaviani et al., 2002) and auditory brainstem response (ABR) 
latency in children with type-1 diabetes compared to controls (Durmus et al., 2004).  To 
obtain a power of β= 0.80 a sample size of approximately 16-18 participants was 
indicated per group.  Based on this information, a sample size of 20 participants per 
group was planned for a total n = 40.  
 
General Sample Characteristics 
 
 The study sample consisted of 20 experimental participants with type-1 diabetes 
(referred to as experimental group) and 20 age-gender matched controls (referred to as 
control group).  Participants with type-1 diabetes were enlisted first and then controls 
were matched for age (within 1 year) and for sex.  Two additional control subjects were 
tested, but excluded due to air-bone gaps > 10 dB HL.  Eighteen of the participants were 
male and 22 were female.  The mean age was 22.9 years (control group) and 22.6 years 
(experimental group) (standard error of the mean (SEM) ± 0.59 control, ± 0.63 type-1).  
Thirty-seven of the participants were White/Caucasian, while two were Black/African 
American (1 control group, 1 experimental group) and one was Asian (control group).  
All participants reported average to above average socioeconomic status (SES) except 
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one (control group) who reported lower than average SES (see question 9 in Appendix 
C).  Participants were college graduates or currently attending college or high school. No 
significant medical histories associated with hearing loss were reported.  Several 
participants reported regular use of aspirin (2 experimental, 1 control), but not within 48 
hours of the testing sessions and were therefore not excluded. 
 
Experimental Group Specific Characteristics 
 
 The experimental group consisted primarily of patients from the Vanderbilt 
University Eskind Diabetes Clinic.  The age of diagnosis of type-1 diabetes ranged from 
3 to 24 years (mean 13.8, SEM ± 1.25).  The duration of diabetes ranged from 1 to 21 
years (mean 8.85 ± SEM 1.45).  Sixty percent of the experimental group treated their 
diabetes with a pump device, while the other 40% used shots. No experimental subjects 
reported nephropathy, retinopathy, or neuropathy associated with their diabetes. Table 2-
1 presents the frequency of other co-morbidities.  Very few complications were reported 
in this sample. 
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Table 2-1.  Frequency of Diabetes Related Complications 
Diabetes Related Complication Frequency  
High Blood Pressure 2 
High Cholesterol 2 
Hypertension 1 
Hypotension 3 
Other Cardiovascular Disease 0 
Addison Disease 0 
Celiac Disease 1 
Coma 3 
Rheumatoid Arthritis 0 
 
 
Glycated hemoglobin (HbA1c) levels (5 previous levels over approximately the 
past 15 months) were obtained from each experimental participant’s medical records.  
The HbA1c levels ranged from 5.54 to 12.0 %, (mean 7.75%, SEM ± 0.36).  Further 
details on the experimental group including severity/control will be explored in the 
Chapters VI and VII  (Covariates and Noise Exposure, respectively), including potential 
influence on auditory function. 
 
Research Approval and Recruitment 
 
Approval was obtained from the Vanderbilt Institutional Review Board (VIRB) to 
conduct this study.  All participants provided informed consent using VIRB approved 
materials and procedures. Participants were advised they could withdraw from the study 
at any time; none withdrew. 
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CHAPTER III 
 
BASIC AUDIOLOGICAL BATTERY 
 
Literature Review  
 In the context of this dissertation, basic audiological battery will refer to pure tone 
thresholds and immittance testing. The introduction of pure tone audiometry allowed 
researchers a common measure to characterize changes in auditory sensitivity associated 
with diabetes.  The typical pattern of hearing loss described in the early literature was a 
progressive, bilateral sensorineural hearing loss (SNHL), affecting the high frequencies 
(Jorgensen and Buch, 1961; Taylor and Irwin 1978; Kurien et al., 1989).  However, 
exceptions have been reported, including acute (Jorgensen and Buch, 1961), unilateral 
(Jorgensen and Buch, 1961), and low to mid frequency loss (Jorgensen and Buch, 1961; 
Tay et al., 1995). Other studies have demonstrated pure tone threshold changes with 
diabetes across low, mid, and high frequencies (Ferrer et al., 1991; Cullen and 
Cinnamond, 1993).  On the other hand, many studies have demonstrated no relationship 
between pure tone thresholds and diagnosis of diabetes (Axelsson and Fagerberg, 1968; 
Gibbin and Davis, 1981; Osterhammel and Christau, 1980; Seiger et al., 1983). 
Unfortunately, most of these studies did not discriminate between types of diabetes 
(according to modern criteria), included both young and old participants, and generally 
lacked matched controls.   
Studies specifically on type-1 diabetes demonstrated conflicting results.  
Osterhammel and Christau (1980) and Sieger et al (1983) each demonstrated normal pure 
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tone thresholds, while Ferrer et al. (1991) reported elevated pure tone thresholds across 
all frequencies tested (250-8000 Hz).  All of these studies were performed in younger 
populations under 40 years of age.  More recent studies incorporating otoacousitc 
emissions (OAE) and auditory brainstem responses (ABR) have tended to control for 
pure tone thresholds, requiring “normal” thresholds for participation. 
In addition to the above case and case-control studies, several epidemiological 
studies have examined pure tone thresholds as an outcome for assessing the relationship 
between diabetes and hearing loss. The Framingham Heart Study examined audiometric 
data and found no association between diabetes and hearing loss for pure tone averages 
(PTA) (Gates et al., 1993).  Data from the Beaver Dam Aging Study (PTAs) revealed 
only a weak association.  A five-year prospective study of diabetes and hearing loss was 
performed in the veteran population.  Vaughan et al. (2005) analyzed PTAs including 
extended high frequencies and found that diabetic patients under the age of 60 years were 
at risk for greater hearing loss at frequencies greater than 10000 Hz. These findings were 
supported by a recent study by Austin et al. (2009).  They compared medical records 
from a Veteran Affairs database.  Diabetes was classified as insulin dependent (IDDM) 
and non-insulin dependent (NIDDM).  Slight differences were seen for IDDM and 
NIDDM, but overall diabetes was associated with an increased risk of elevated PTAs 
particularly in adults under 50 years of age. An NIH sponsored study by Bainbridge et al. 
(2008) found evidence from PTAs of over 5000 participants that diabetes was an 
independent risk factor for hearing loss. Finally, Agrawal et al. (2009) examined adults 
aged 20 to 60 years of age who participated in the National Health and Nutrition 
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Examination Survey.  They also demonstrated diabetes as an independent risk factor for 
hearing loss.   
The studies discussed above have focused primarily on the existence of 
sensorineural hearing loss with limited consideration of middle or external ear pathology 
(conductive), with most controlling for conductive hearing loss.  In the early 1980s and 
1990s consideration of potential effects on middle ear function were initiated.  Most 
studies indicated no effect of diabetes on tympanometry (Osterhammel and Christau, 
1980; Seiger et al., 1983) or middle ear muscle reflexes (Seiger et al., 1983).  However, 
two studies by Virtaniemi et al. (1993, 1994) demonstrated diminished tympanogram 
amplitudes and middle ear muscle responses (respectively) despite absence of conductive 
hearing loss.  Stiffening of the middle ear system was proposed as the underlying 
mechanism for both findings related to changes in vascular supply to middle ear 
structures.  No neural mechanism was proposed related to diminished MEMR. 
 
Purpose and Hypothesis 
 The purpose of the basic audiological battery portion of this study was to rule out 
presence of conductive pathology and determine overall hearing threshold sensitivity.  In 
addition, extended high frequency pure tone thresholds (10000-16000 Hz) were obtained.  
Several studies have indicated that extended high frequency thresholds may reveal early 
signs of hearing loss prior to changes in the traditional frequency range tested in clinical 
evaluation (250-8000 Hz) (Fausti et al., 1993; Knight et al., 2007; Somma et al., 2008) 
including two diabetes studies (Vaughan et al., 2005; Austin et al., 2009).  We 
hypothesized that each group would demonstrate similar pure-tone thresholds at 
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frequencies 250-8000 Hz.  We expect the experimental group to show poorer extended 
high frequency thresholds.  However, we did not expect any difference for immittance or 
MEMRs. 
 
Methods 
 Procedures and Data Analysis.  All testing was performed in both the right and 
left ears of the participants. An otoscopic exam was completed to rule out presence of 
occluding cerumen. Pure-tone thresholds were tested with a Grason Stadler GSI 61 
audiometer (Eden Prairie, MN) using Etymotic ER3A insert earphones (Elk Grove 
Village, IL), a RadioEar B71 bone conduction stimulator (New Eagle, PA), and 
Sennheiser HDA 200 extended high frequency (10000-16000 Hz) headphones 
(Wedemark, Germany).  All testing was completed in a double-walled sound treated 
room.   
The audiometer and transducers were calibrated by a certified Med-Acoustics 
engineer (Atlanta, GA) prior to the initiation of the study to American National Standards 
Institute (ANSI S3.6-1989, 1996, 2004 and 3.43).  In brief, the transducer sound pressure 
level (SPL) was measured in a coupler (dependent on transducer type) using asound level 
meter (Quest OB-300, Oconomowoc, WI), while the audiometer was set at 70 dB HL (55 
dB HL at 16000 Hz).  This was performed for each frequency from 125-16000 Hz 
(ER3A, 125-8000 Hz and Sennheiser HDA 200, 8000-16000 Hz).   A biological check 
was performed before testing each participant.    
Air-conduction thresholds were measured at octave and inter-octave frequencies 
from 250-16000 Hz and bone conduction in octave steps from 250-4000 Hz, in 5-dB 
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steps using a standard method of limits technique (Hughson and Westlake, 1944).  
Participants were excused if an air-bone gap > 10 dB HL was indicated and 
recommendations for follow-up with a health care professional were made.  Pure tone 
averages (PTA) for low (PTAL; 250-1500 Hz), high (PTAH; 2000-8000 Hz), and 
extended-high frequencies (PTAE; 10000-16000 Hz) were calculated and compared 
between ears and groups. 
Middle ear testing, tympanometry and middle ear muscle reflex (MEMR) 
thresholds for tones, were measured to rule out middle ear dysfunction and provide a 
measure of lower brainstem function, respectively.  Testing was performed in a quiet lab 
space while the participant was seated in a comfortable chair.  Both ipsilateral and 
contralateral MEMR thresholds (500-4000 Hz) were measured in 5 dB steps on a Grason 
Stadler GSI TympStar (Eden Prairie, MN). The equipment was checked in a 2 cc coupler 
prior to testing participants.  Tympanometry was compared to normative values (ASHA, 
1990).  All subjects met normative criteria.  MEMRs (500-4000 Hz) were compared 
between ears and groups. 
 
Statistical Analysis 
All 40 participants (20 control, 20 experimental) were included in the analysis.  
The data from the audiological battery (pure-tones, immittance, MEMR) were first 
entered into Excel spreadsheets and subsequently transferred to SPSS (version 18) for 
statistical analyses.  The first step in the statistical analysis was to compare results in the 
left versus right ears to determine if an ear difference existed and if ear data could be 
averaged for further analyses.  Analyses of Variance (ANOVA) were performed on the 
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three PTAs (PTAL, PTAH, and PTAE) and MEMR (500, 1000, 2000, and 4000 Hz), to 
compare data from the separate ears.  A significance criterion of p < .05 was selected.  No 
significant differences were seen between ears, therefore, left and right ear data were 
averaged.  Second, the ear-averaged data were compared between groups.  ANOVAs 
were performed to compare mean PTAs and MEMRs between groups. 
 
Results 
All participants had thresholds within normal ranges (< 20 dB HL) for 
frequencies with normative data (250-8000 Hz) and no air-bone gap greater than 10 dB.   
No significant differences were found between groups for PTAs (PTAL, PTAH, and 
PTAE) or MEMR (500, 1000, 2000, and 4000 Hz).  Thus our hypothesis was confirmed, 
except for the extended high frequency thresholds (PTAE).  Figure 1 displays the average 
SPL in dB (SPLogram) for each group.  The SPL was determined by converting dB HL 
to dB SPL using the appropriate references for each type of transducer (ER3A and 
Sennheiser HDA200) available in the GSI 61 clinical audiometer manual based on the 
ANSI standards listed above.   The further analyses were performed to explore 
covariates; these findings are discussed in the two sections in Chapters VI and VII titled 
“Covariates” and “Noise Exposure”, respectively. 
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Figure 3-1.  Average Sound Pressure Level Thresholds.   The average thresholds 
in the left (solid) and right (dash) ears in the control (black) and experimental 
group (type-1, in grey) are displayed.  No significant differences were seen 
between ears or between groups at any threshold or PTA (PTAL, PTAH, and 
PTAE).  Mean and SEM data are shown. 
 
 
Discussion 
The basic audiological analysis of pure tone thresholds and middle ear function 
demonstrated normal hearing and no significant ear effect or difference between the 
control and experimental groups.  These findings are consistent with case-control studies 
performed in younger diabetes subjects (< 40 years of age) and matched-control samples 
(Osterhammel and Christau, 1980; Sieger et al., 1983). We did expect a difference for 
PTAE (extended high frequencies), but did not find one.  Several studies have indicated 
that extended high frequency testing can demonstrate early signs of cochlear damage 
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(Fausti et al., 1993; Knight et al., 2007; Somma et al., 2008).  Two studies (Vaughan et 
al., 2005; Austin et al., 2009) found poorer pure tone thresholds in adults with diabetes in 
frequencies above 10000 Hz.  However, the age of the population was much older in both 
studies (veterans, ~25-80 years of age) and both were population based epidemiological 
studies with larger sample sizes (n > 300).  Therefore, their results may not be captured in 
a case-control study design.  A threshold method with greater sensitivity (e.g., three 
interval forced choice) may have uncovered differences, but was excluded due to time 
demand and preference for commonly used clinical methods. 
Nonetheless, the majority of previous studies that examined pure tone thresholds 
lacked an appropriate matched control population and/or did not consider type of 
diabetes.  These factors likely underlie the contradictory findings in the literature. Based 
on these findings, the clinical diagnosis would be consistent with normal auditory 
sensitivity for each of our groups. 
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CHAPTER IV 
 
COCHLEAR FUNCTION 
 
Literature Review 
The existence of otoacoustic emissions (OAE), first proposed by Gold (1948) and 
demonstrated experimentally by Kemp (1978), provided a glimpse into the mechanics of 
the cochlea not previously possible.  Otoacoustic emissions represent measurable sounds 
produced as a by-product of cochlear function.  These emissions are usually measured 
with a sensitive microphone placed in the external ear canal of the subject.  As the 
theoretical, physical, and physiological understanding of sources contributing to OAEs 
continue to develop, earlier indications of cochlear pathology become possible, 
potentially allowing intervention and prevention of subjective pathology (e.g., pure tone 
thresholds).   
Sources and Types of OAEs.  The primary sources of OAEs are dependent on the 
evoking stimuli.  The proposed mechanics include a non-linear distortion source (non-
linear referring to compressive growth with increase in stimulus level) and coherent-
reflection source (both involving a backward travelling wave on the basilar membrane), 
fast wave compression (fluid compression), and multiple interactions not fully 
understood and debated (Shera, 2004; Ren et al., 2006).  Excellent reviews are available 
for the interested reader (Shera, 2004; Shera and Guinan, 2008; Johnson, 2010).   
Four primary categories of OAEs exist, spontaneous otoacoustic emissions 
(SOAE), stimulus frequency otoacoustic emissions (SFOAE), transient evoked 
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otoacoustic emissions (TEOAE), and distortion product otoacoustic emissions (DPOAE).  
SOAEs represent the simplest form of an OAE, as they do not require an evoking 
stimulus.  SOAEs are theoretically generated by repeated coherent-reflections (from 
existing perturbations) of a travelling wave back and forth on the basilar membrane 
(Shera, 2004).  These reflections become “in phase” and result in a measurable SOAE 
(Boul and Lineton, 2010).  SFOAEs are evoked by a single tone and believed to be due 
primarily to the coherent-reflection source similar to SOAEs, but acquired by an evoking 
stimulus (Shera, 2004).  TEOAEs (typically evoked with a click stimulus) have been 
demonstrated primarily to have a coherent-reflection source (Kalluri and Shera, 2001), 
but also have been shown to have a non-linear distortion portion (Yates and Withnell, 
1999). For TEOAEs, the 80 dB peak SPL “nonlinear” mode represents the traditional 
screening protocol.  The term “nonlinear” refers to a change in the stimulus polarity 
(three 80 dB peak SPL positive polarity clicks and one 90 dB peak SPL negative polarity 
click). This should not be confused with the nonlinear distortion source (too be 
explained). 
DPOAEs are evoked using two simultaneous pure-tones at slightly different 
frequencies (f1, f2; with f2 > f1) and variable intensities.  The abbreviation f1 denotes the 
lower frequency in the pair and f2, the higher frequency.  Similarly, L1 represents the 
intensity level of the lower frequency tone and L2, the intensity of the higher frequency.  
The f2/f1 represents the ratio of the frequencies of the two tones, with a ratio in the range 
of 1.20 to 1.22 typically used in humans as these ratios yield the higher DPOAEs.  The 
largest distortion product in humans is the cubic distortion product, noted as 2f1-f2.    
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DPOAEs include contributions from both the coherent-reflection and the non-
linear distortion sources (two-source model, not to be confused with the “nonlinear” click 
mode for TEOAEs), but at different locations along the basilar membrane.  The distortion 
source component arises from nonlinear interaction of two relatively high-level stimuli at 
a location near the f2 place where the DPOAE is generated, while the reflection 
component is generated near the 2f1-f2 (typically the largest DPOAE) characteristic place 
from a relatively low-level stimulation.  Both sources contribute to the DPOAE measured 
in the ear canal (Shera and Guinan, 1999).  Figure 4-1 provides an overview of the two-
source OAE model. 
 
Figure 4-1.  Two-Source DPOAE Model.  In this simplified schematic two 
primary tones have been presented (bottom tracing marked f1 and f2) in the ear 
canal, the overlap region of these two tones produces a non-linear response 
(represented by the line titled distortion source with the circle) that travels both 
back to the middle ear (to stapes) and toward the apical portion of the cochlea.  
The wave traveling to the apex reaches a region of maximum excitement (2f1-f2, 
the small wave to the far right in the bottom tracing) and results in the formation 
of another traveling wave back to the middle ear (top line titled reflection source).  
This figure is from Shera (2009). 
 
 
One important feature of the two-source model of DPOAEs is the relative phase 
change with varied stimulus frequency.  As stimulus frequency is varied, the phase of the 
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response arising from the reflection source changes rapidly, while the phase of the 
response arising from the distortion source changes slowly.  This relationship is based on 
a theoretical relationship between the stimulus and the source first proposed by Kemp 
and Brown (1983).   
The coherent-reflection source is created by a place-fixed pre-existing 
perturbation (cell to cell force interactions in a normal cochlea) that scatters the incoming 
stimulus.  Since the source (pre-existing perturbation) is fixed in place, as the stimulus 
frequency changes so does the phase lag.  On the other hand, the non-linear distortion 
source is not due to a pre-existing perturbation, but is actually induced by the stimuli.  
Therefore, the source is fixed to the wave induced by the stimulus, so the source of the 
response moves with the wave of the stimulus resulting in zero phase lag. (Shera, 2004).  
Figure 4-2 illustrates the phase-source relationship.   
 
 
Figure 4-2.  Phase-source Relationship.  This figure depicts the change in phase 
with frequency for the two components.  In this figure the reflection component is 
the darker line (residual) and the distortion component is the lighter line (NL 
component).  As frequency increases minimal change in the phase occurs for the 
distortion component, but the reflection component phase lag increases.  This 
change in phase is based on the two-source model discussed above.  The 
remaining data in the figure box are hidden by the NL component line (lighter 
line). 
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Fine Structure in Otoacoustic Emissions.  The interaction of these two sources, as 
in DPOAEs, can result in constructive and destructive interference.  When the two 
components are in phase, the magnitude of the overall response is greater than the 
distortion component alone; when out of phase, the magnitude is lower than the distortion 
component.  As a consequence, DPOAEs show quasi-periodic peaks and valleys in 
amplitude when the response is measured in small frequency steps, referred to a fine 
structure (Johnson, 2010).  When DPOAEs are measured at larger frequency steps the 
investigator cannot be sure where a particular DPOAE falls within the fine structure (i.e., 
at a peak or valley) and may incorrectly infer a dip in the response as representing a 
pathology rather than as a normal dip at that region in the fine structure (Long et al., 
2008).  Figure 4-3 provides an example of DPOAE fine structure.  
 
 
Figure 4-3.  Fine Structure.  The figure shows the DPOAE fine structure (thin 
black line) and noise floor (grey fill).  The number of fine structures is created by 
the constructive and destructive relationship between the non-linear distortion and 
coherent-reflection sources. 
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This interaction of the reflection and distortion components has led to a series of 
studies seeking to separate and quantify these two sources from the existing fine 
structure.  The two primary methods for separating fine structure components have been 
(1) a suppressor stimulus, to eliminate the reflection source and (2) a time-windowing 
approach, separating components based on their phase relationship.  The suppressor 
approach was limited due to loss of the reflection source from the measure, artifact of the 
suppressor stimulus on the response, and potential to diminish not only the reflection 
source, but the generator source as well (Johnson, 2010).  The time-windowing approach 
has been limited by the time demand to record DPOAEs at many closely spaced 
frequencies.   
In 2008, Long et al. introduced a frequency sweep approach not dependent on 
performing small distinct frequency steps with fixed primaries.  The primary tones were 
swept in frequency while maintaining a constant ratio.  The responses generated from this 
paradigm have been demonstrated to be consistent with fine structure seen with small 
frequency steps with fixed primaries, and to provide a much more time efficient measure.  
Further details on the sweeping primary paradigm are available in Long et al. (2008). 
Sensitivity to Pathology.  Numerous studies have demonstrated that OAEs (all 
types) show susceptibility to cochlear pathology, with change in pure tone thresholds and 
even prior to changes in pure tone thresholds. For example, Attias et al. (1995) found 
reduced TEOAE (80 dB peak SPL “nonlinear” clicks) responses in military personnel 
with significant noise exposure, but normal pure tone thresholds.  Similar findings using 
TEOAEs and DPOAEs were reported by Lucertini et al. (2002) and Sisto et al. (2007). 
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Sisto et al. (2007) provide a comprehensive review of the literature for the interested 
reader. 
Kummer et al. (1998) demonstrated changes in DPOAE amplitudes with change 
in stimulus levels.  The growth of DPOAEs is compressive in normal hearing participants 
(saturating at moderate levels).  In other words, as stimulus intensity increases the growth 
of the DPOAE amplitude reaches a point of maximal excitement; this is related to the 
compressive non-linear nature of the DPOAE response.  Kummer et al. (1998) showed 
that participants with cochlear impairment demonstrated reductions in DPOAEs at low 
stimulus levels, but less reduction at higher stimulus levels, such that the growth of the 
DPOAE became linear.  
The contribution of two sources (as in DPOAEs) arising from different properties 
for the length of the basilar membrane may introduce variability into responses where 
cochlear health is not constant.  For example, Mauermann et al. (1999) showed that the 
contribution of the reflection-source component is absent whenever hearing loss occurs at 
the DPOAE 2f1-f2 place, while the contribution from sources more related to the non-
linear distortion may be observed even in cases of mild hearing loss.  However, with a 
mild sloping high frequency hearing loss, if the more apically located 2f1-f2 region is 
preserved the reflection component may be preserved as well (Johnson, 2010).  Thus the 
effect of hearing loss on cochlear fine structure and its sources may be dependent on the 
specific pathology associated with the loss (Abdala and Dhar, 2010).   
Diabetes and OAE Responses.  Several groups have examined the influence of 
diabetes on OAE responses.  Di Leo et al. (1997) and Di Nardo (1998) examined 
DPOAEs (Level: L1=L2=70 dB SPL, f2/f1=1.22) and TEOAEs (80 dB peak SPL 
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“nonlinear” clicks; a description of nonlinear clicks is provided in the methods section of 
this chapter) in young adults with insulin dependent diabetes mellitus (IDDM) and 
normal pure-tone thresholds compared to matched-controls.  They found reduced 
TEOAE amplitudes in diabetic participants with reduced nerve conduction velocity 
(NCV), but not in diabetic participants with normal NCV. DPOAE amplitudes were 
reduced in both patients with NCV and without reduced NCV. The researchers 
contributed the changes in OAE amplitudes to microvascular compromise, despite 
measurement for presence of microangiopathy.   
Reduced DPOAE (L1=L2, 35-70 dB SPL, f2/f1=1.22) findings were also reported 
in normal hearing young adults with type-1 diabetes (Lisowska et al., 2001). Despite the 
fact that these researchers evaluated numerous stimulus levels, growth of DPOAE 
amplitudes was not discussed, but significant differences were seen at each level.  In 
contradiction to the suggested mechanism proposed by the previous studies, they reported 
no relationship to the presence of microangiopathy (evaluated by opthalmoscopy and 24 
hour albumin excretion rate), finding altered responses in both patients with 
microangiopathy and without.  The authors suggested that the impairment was related to 
early metabolic complications, including nonenzymatic glycation related to excess free 
radical activity, but not directly due to microangiopathy.  In 2002 Ottaviani et al. 
evaluated TEOAEs (to 75-90 dB peak SPL “nonlinear” clicks) and DPOAEs (L1=L2=70 
dB SPL, f2/f1=1.22) in normal hearing young adults with type-1 diabetes. Significantly 
reduced amplitudes were seen compared to controls (not matched) for both types of OAE 
responses.   
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In contrast, Namyslowski et al. (2001) examined TEOAEs (80, 70, and 60 dB 
peak SPL, “nonlinear” mode) in children from 6 to 16 years of age.  No significant 
difference in TEOAE amplitude was seen compared to controls at any level.  Ugur et al. 
(2009) found comparable results to the previous study with no difference in TEOAE (75-
85 peak SPL, “nonlinear” click) or DPOAE (L1=L2=70, f2/f1=1.22) amplitudes in 
children with type-1 diabetes compared to age-matched controls.  In addition, they found 
no difference in SOAEs.  No previous studies have examined DPOAE fine structure in a 
population with diabetes. 
 
Purpose and Hypothesis 
 We included an assessment of cochlear function incorporating OAEs to identify 
signs of damage that may have not been observed in pure-tone threshold assessment.  
Numerous studies reviewed have demonstrated the ability of OAEs to identify early signs 
of cochlear pathology prior to changes in thresholds.  The purpose of this study section 
was to perform a comprehensive assessment of cochlear function using OAEs.  
Procedures incorporated commonly used clinical protocols (as described in the literature 
review) and novel research protocols, (e.g., sweeping primary tones DPOAE paradigm 
developed by Long et al., 2008) that allow collection of data needed for separate 
quantification of reflection and distortion components of cochlear responses.  The 
primary objective was to compare cochlear responses between groups.  The secondary 
objective was to explore the utility of these measures in identifying early signs of 
cochlear pathology prior to changes in pure tone thresholds.  Further discussion of this 
secondary objective is presented in Chapter IX.   
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We hypothesized that OAE amplitudes would be diminished in the experimental 
group compared to the control group and that the most prominent differences would be 
seen in the DPOAE fine structure outcomes.  Further analyses of the influence of 
Covariates and Noise Exposure will be described in subsequent chapters.    
 
Methods 
 All cochlear function testing was performed in a double-walled sound treated 
room, while the participant was seated in a comfortable chair.  A closed-captioned movie 
was viewable through the window (sound treated) of the room on a monitor located in the 
adjoining room.  Participants were instructed to sit quietly and try to minimize 
physiological noise (heavy breathing, movement, etc).   
 TEOAE Procedures.  TEOAEs were recorded with the Intelligent Hearing 
Systems (IHS) SmartTrOAE (Miami, FL) and the Etymotic Research (ER) 10D probe 
microphone (Elk Grove Village, IL).  The IHS system was calibrated using the Brüel and 
Kjaer Pulse (software version 11.0).  TEOAE responses were obtained with 65 dB peak 
SPL “linear” clicks and 80 dB peak SPL “nonlinear” clicks in the right and left ears with 
the 10D probe inserted in the ear canal using an ER10D foam tip.  The 80 dB peak SPL 
“nonlinear” mode represents the traditional clinical screening protocol.  The “nonlinear” 
in this instance refers to a change in the stimulus polarity (three 80 dB peak SPL positive 
polarity clicks and one 90 dB peak SPL negative polarity click).  The duration of each 
click was 75 usec and 1024 stimuli were presented and averaged at each level. 
The advantage of the “nonlinear” mode is that artifacts can easily be reduced 
since they add linearly, while the actual OAEs based on their inherent nonlinear growth 
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(nonlinear in this case referring to compressed growth with increase in stimulus level), do 
not add in a linear manner.  Though the “nonlinear” mode is preferred at higher 
intensities, at lower intensities (i.e. 65 dB peak SPL) stimuli with a constant polarity (so-
called “linear”) can be used.  To control for potential stimulus artifact occurring early in 
the response, the Kresge EchoMaster Program (version 4.0; Wen et al., 1993) was used to 
quantify emission amplitude in an 8- to 18-ms time window (see later discussion). 
Basic DPOAE Procedures. A screening DPOAE was performed using f2 tone 
frequencies of 500-8000 Hz, 4 frequencies per octave, f2/fl ratio of 1.22, and intensity 
levels of L1=65, L2=55 dB SPL.  The same calibrated IHS system (but the SmartOAE 
program) and probe were used as in TEOAE recordings; responses were measured in 
both ears.   
DPOAE Fine Structure Procedures. A custom designed DPOAE fine structure 
system (NIPR, C. Tallmadge) interfaced with a Stanford Research Systems low-noise 
amplifier and an Etymotic Research ER10B low-noise probe microphone was used to 
measure DPOAE fine structure.  Stimuli were calibrated using the Kemar (Knowles 
Electronics Manikin for Acoustic Research) and the Brüel and Kjaer Pulse system to 
estimate the level at the eardrum.  At the start and end of each session, white noise was 
played through each tube phone in turn, recorded and analyzed using a Fast Fourier 
Transfer (FFT) to evaluate the probe fit and ensure that levels near 1000 Hz approximate 
the required stimulus level for each output. 
Custom programs for a Macintosh computer (MAC OS) developed by C 
Talmadge were used to generate the stimuli and record the ear canal signals.  Two ER2 
(Etymotic Research, Elk Grove Village, IL) tube phones were connected to a two-port 
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ER10B low-noise microphone, which was inserted in the ear canal using an ER10A 
disposable tip.  Before being digitized by the MOTU (Cambridge, MA) 828 (24 bit, 
44100 samples/sec), the signal from the microphone was conditioned, pre-amplified and 
filtered (300-10,000) by a Stanford (Sunnyvale, CA) SR650 low-noise amplifier under 
computer control.   
Tone pairs were presented using an up-, down-sweeping paradigm (Long et al., 
2008), an f2/f1 ratio of 1.22, f2 range from 1000-11314 Hz (7 second sweep, 
approximately 2 seconds per octave), and intensity levels L2 =35, 50, 65 and L1 = 39 dB 
SPL + 0.4 x L2.   These intensities were based on the so-called “scissors” paradigm that 
theoretically accounts for the different compression of an f2/f1 ratio of 1.22 at the DPOAE 
overlap region (distortion source) (Kummer et al., 2000).  Sweeps were obtained for each 
primary level and averaged to increase the signal-to-noise ratio between the measured 
DPOAE and background noise.  The number of sweeps obtained at each level depended 
on the primary level, with the lowest level requiring more sweeps (L2=35, N=60) than 
higher presentation levels (L2=50, N=36; L2=65, N=24).  Testing was performed in both 
ears and at the three different levels in one session.   
 
Data Analysis 
 TEOAE and Basic DPOAE.  TEOAE data and noise levels for the 80 dB peak 
SPL nonlinear clicks in the 1000-4000 Hz range were transferred to an Excel database 
(dB Response and dB Noise).  TEOAE 65 dB peak SPL linear click data were first 
analyzed using the Kresge EchoMaster software in an 8-18 ms window to minimize 
contributions of stimulus artifact to the data being analyzed.  In the case of the 65 dB SPL 
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level, use of the window approach excludes ability to examine frequency specific data.  
Therefore, the overall root mean squared (RMS) amplitude and noise level were collected 
and transferred to an Excel database.   
In addition, the basic DPOAE (2f1-f2) amplitude and noise floor data were entered 
into an Excel database.  The TEOAE and DPOAE data were then transferred to an SPSS 
database for statistical analysis.  All 40 participants were included in the analysis. 
DPOAE fine structure.  Spectrograms of the individual sweeps were visually 
inspected and noisy sweeps were eliminated before averaging at each level.  The 
remaining sweeps with identical stimulus conditions (sweep direction and stimulus 
intensity) were averaged to reduce the noise floor and subtracted to estimate the noise 
floor.  Up- and down-sweeps were analyzed independently and compared as a cross-
check.  The remaining data analyses were restricted to the up-sweep data.  The up-sweep 
and down sweep-data provide comparable fine structure outcomes (Long et al., 2008) 
A least-squares fit (LSF) procedure was used to extract the level of the DPOAE 
generator component for each averaged sound file using overlapping analysis windows. 
This yielded estimates at every 2 Hz around 1000 Hz and every 6 Hz above 4000 Hz 
(Long et al., 2008).  Software developed by Dr. C. Talmadge based on the program NIPR 
was used to separate the nonlinear distortion and linear reflection components.  NIPR is a 
MATLAB-based analysis program that uses an Inverse Fast Fourier Transfer (IFFT)-
based algorithm to convert the frequency domain complex-valued DPOAE amplitude to 
the time-domain, where a time window filter is applied to separate the components based 
on their phase lag. Additional procedural details on LSF and NIPR are available in Long 
et al. (2008). 
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Three primary outcomes were extracted from the data: (1) the overall fine 
structure frequency count, (2) RMS levels in 1/3 octave bands (dB SPL) and (3) the slope 
of the phase for the nonlinear distortion and linear reflection components.  Fine structure 
features (peak count) were extracted with a custom automatic algorithm in MATLAB 
based on the criteria set forth by Dhar and Abdala (2007) and Abdala and Dhar (2010).  
The RMS amplitude was calculated using a program developed by C Talmadge, while the 
slope of the phase was calculated by using the slope function to the raw data in Excel. 
In brief, the signal to noise ratio was > 6 dB, fine structure maxima > 2.5 dB, 
where depth was computed as 20 log10 (Pmax/Pav_min), where Pmax was the DPOAE level at 
a maximum and Pav_min was the average DPOAE level of the preceding and following 
minima; and spacing ratio < 25 (f/∆f), where f was the geometric mean between two 
adjacent minima frequencies and ∆f was the frequency separation between them.  The 
total number of fine structure peaks were counted in the frequency range 1000-6000 Hz 
to limit influence of noise and to maintain consistency with the procedures of Abdala and 
Dhar (2010).  In addition, the change in each outcome with increase in level was 
calculated by taking the difference for each outcome (Fine structure count at 35 dB SPL – 
65 dB SPL; RMS levels at 65 dB SPL- 35 dB SPL; Phase slope at 35 dB SPL – 65 dB 
SPL).  These data were entered into an Excel database and later transferred to an SPSS 
database for statistical analysis.  Eight participants were excluded due to high noise and 
artifact in the response (3 control and 5 experimental) for an n = 32.  The better ear (least 
noisy) for each participant was used in the statistical analysis. 
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Statistical Analysis 
 TEOAE and Basic DPOAE.  Statistical analyses were performed using SPSS 
(version 18.0). Data were compared between ears and groups using analysis of variance 
(ANOVA) and p < .05 as the criterion for significance.  First, TEOAE (overall 80 dB and 
65 dB peak SPL and at 1000, 1500, 2000, 3000, and 4000 Hz at 80 only) and DPOAE 
(over f2 range) data were compared across ears.  No significant differences were 
indicated and individual ear data were averaged.  Next, TEOAE and DPOAE noise levels 
were compared between the control and experimental groups (this was done for 
individual ear data). Finally, the TEOAE and DPOAE amplitudes averaged across both 
ears were compared between groups.  Data were excluded if cross-correlations were less 
than 70%.  
DPOAE Fine Structure.  Statistical analysis was performed using SPSS (version 
18.0). Data were compared between groups using analysis of variance (ANOVA) and p < 
.05 as the criterion for significance.  Number of fine structure at each stimulus level, 
RMS level (1/3 octave bands 1000-6000 Hz at each stimulus level), and slope of the 
phase (overall, distortion component, and reflection component) were compared between 
the control and experimental groups.  In addition, the difference at the highest and lowest 
level for each of the above outcomes was computed and compared between groups 
(change with stimulus level).   
 
Results 
 TEOAE.  Both groups showed similar noise floors for all outcomes.  We 
examined two TEOAE intensity levels, the clinical commonly used level of 80 dB peak 
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SPL and a lower level of 65 dB peak SPL.  The 80 dB data were analyzed for overall 
level and at 5 frequencies, 1000, 1500, 2000, 3000, and 4000 Hz. Data at 65 dB were 
only compared for the overall level.  This was limited due to the need to window the 
response to the 65 dB peak SPL stimuli in order to diminish the stimulus contribution 
(explained above).   
No significant differences were seen between groups for either the 80 dB or 65 dB 
peak SPL stimulus noise floor, the overall TEOAE response, or at specific frequencies 
between groups.  However, a trend was present for slightly lower responses in the 
experimental group compared to the control group.  Figure 4-4 shows the mean overall 
TEOAE amplitude for responses to the 65 dB peak SPL “linear” clicks and to the 80 dB 
peak SPL “nonlinear” clicks.  Note the trend of lower amplitude for the experimental 
group, particularly for the 65 dB peak SPL linear clicks stimulus.   
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Figure 4-4.  TEOAE Amplitude by Level and Group.  No significant difference 
was found between groups (p < .05) for responses at 80 dB peak SPL or 65 dB 
peak SPL.  However, a trend for slightly reduced amplitudes was present at each 
level tested in the experimental (type-1) group.  Mean and SEM are shown. 
 
Basic DPOAE.  As reported for the TEOAE data, no significant differences were 
present for noise levels between groups.  Likewise, no significant differences in DPOAE 
amplitudes between groups were indicated.  The average DPOAE responses for each 
group are illustrated in Figure 4-5.   
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Figure 4-5. DPOAE Amplitude by f2.  Comparison of DPOAE responses 
demonstrated no significant difference between groups (p < .05).  However, the 
type-1 diabetes subjects showed a trend for lower level responses.  Mean and 
SEM are shown.  
 
 
 
DPOAE Fine Structure. The fine structure count (number of peaks) is presented in 
Figure 4-6.  A main effect of decrease in fine structure count was found with increase in 
stimulus level (F=6.982, p < .05).  However, the change in fine structure count with 
increase in level was similar between groups (F=1.165, p >.05).  The fine structure count 
was not significantly different between groups at 35 dB SPL (F=1.498, p > .05), but were 
significantly higher in the control group at 50 dB SPL (F=4.229, p <.05) and 65 dB SPL 
(F=4.946, p<.05).  
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Figure 4-6.  Fine Structure Count.  The number of fine structure components at 
each L2 level tested is provided.  The results indicate a higher number of fine 
structure components in the control group, that were statistically significant at L2 
= 50 and 65 dB SPL.  The change in fine structure count from L2 = 35 to L2 = 65 
was similar between groups.  Data for the control group are in black, and 
experimental (type-1) in grey.  Mean and SEM are shown. 
 
 
 The RMS level for each frequency band and level is summarized for each group 
in Figure 4-7.  The overall fine structure RMS (a, top left) and the separated distortion 
component  (b, top right) and reflection component (c, bottom center) are presented. The 
only significant finding for (a, top left) was at the lowest level (L2 =35 dB SPL) and 
frequency (1176 Hz), where the control RMS is significantly greater than type-1 
(F=6.987, p < .05).  Similar, the (b, top right) distortion component RMS was 
significantly higher in the control group at 35 dB SPL, 1176 Hz (F=6.790, p < .05), while 
no other frequency band showed a significant difference.  The majority of the significant 
findings were for the (c, bottom center) reflection component, where significant 
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differences were seen at several frequencies and levels, all in favor of greater RMS in the 
control group.  The significant reflection component RMS findings are summarized in 
Table 4-1. 
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 Figure 4-7.  RMS Amplitude.  The figure presents the RMS for each group at the 
three different L2 levels tested across the center frequency of 2f1-f2.  Top left illustrates 
the RMS for the overall fine structure, top right the distortion component, and bottom 
center the reflection component. The RMS amplitudes for the two top figures are very 
similar as the distortion component provides the primary RMS amplitude source to the 
both responses.  However, the separated reflection component (bottom center) is 
diminished in the type-1 diabetes group.  Mean and SEM are shown. 
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Table 4-1.  Significant Reflection Component RMS findings.  The mean data and 
SEM are provided graphically in the previous figure. 
 
Reflection Component F 
35 dB @ 1176 Hz 6.243 
35 dB @ 1482 Hz 5.128 
50 dB @ 1482 Hz 5.692 
65 dB @ 1482 Hz 9.217 
35 dB  @ 1866 Hz 20.439 
50 dB @ 1866 Hz 8.898 
65 dB @ 1866 Hz 5.756 
35 dB @ 2531 Hz 7.748 
50 dB @ 2531 Hz 8.674 
65 dB @ 2531 Hz 7.470 
 
 
In addition to the RMS amplitude, we examined growth of the response, again for 
overall fine structure RMS and each component.  Table 4-2 summarizes the significant 
findings.  In each case the largest growth with increase in level was seen in the type-1 
diabetes group (i.e., less compression). 
 
Table 4-2.  Fine Structure with Change in L2 Level.  The growth of RMS 
amplitude was significantly greater in the type-1 diabetes group.  The diminished 
response at the lowest stimulus level (L2=35 dB SPL), but comparable high-level 
response makes the response growth larger in the type-1 diabetes group. 
 
Change in Fine Structure Control Type-1 Control 
SEM 
Type-1 
SEM 
F 
1176 Hz Fine RMS 6.163 9.499 .659 .748 11.459 
1176 Hz Distortion RMS 6.293 9.666 .710 .651 12.024 
1482 Hz Fine RMS 8.933 11.956 .691 .946 6.877 
1482 Hz Distortion RMS 9.309 12.393 .647 .948 7.513 
1866 Hz Fine RMS 5.149 7.629 .679 .764 5.922 
1866 Hz Distortion RMS 5.575 7.835 .688 .778 4.765 
1866 Hz Reflection RMS .6258 3.990 .684 .831 9.985 
2962 Hz Refection RMS 4.948 8.884 1.07 1.25 5.781 
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A comparison of the slope of the phase for each component is provided in Figure 
4-8.  The slope of the distortion component did not significantly change with increase in 
stimulus level (F=3.492, p > .05), but remained around zero.  On the other hand, the slope 
of reflection component decreased significantly with increase in stimulus level 
(F=24.022, p < .05).  No significant differences were found between groups for phase 
slope for either component or any level.  In addition, no significant differences between 
groups were found for change in slope with increase in level for either component 
(distortion [F=.080, p > .05]; reflection [F=.028, p > .05]) .  
-0.1 -0.05 0 0.05
35 Distortion
50 Distortion
65 Distortion
Control
Type-1
Phase Slope (chg in f/chg in phase) 	   -2 -1.5 -1 -0.5 0
35 Reflection
50 Reflection
65 Reflection
Control
Type-1
Phase Slope (chg in f/chg in phase)  
Figure 4-8.  Slope of the Phase.  The individual components are separated and the 
slope of the phase was calculated, where slope = Δ phase/Δ frequency.  The slope 
is much higher in the reflection component (right panel), as the phase changes 
greatly with frequency.  However, phase change in the distortion component (left 
panel) is minimal.  The increase in stimulus level reduces the contribution of the 
reflection component, which is a lower-level evoked response.  However, the 
increase in diminishes mixing of the two-sources and the distortion component 
moves around zero.  The group comparison for each level-component 
combination and change with increase in L2 was not significant.  Mean and SEM 
are shown. 
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Discussion 
 Our previous review of the literature highlighted the inconsistencies among 
studies regarding the relationship between OAE responses and diabetes. The previous 
studies that have focused on younger groups and involved matched controls found similar 
responses between experimental participants and controls (Di Leo et al., 1997; Di Nardo 
et al., 1998; Namyslowski et al., 2001; Ugur et al., 2009). However, our results are in 
contradiction to the reduced OAE amplitudes reported by Lisowska et al. (2001) and 
Ottaviani et al. (2002).  While our basic TEOAE and DPOAE responses revealed no 
significant differences, an obvious trend for reduced amplitudes in experimental 
participants was observed.   
 Fine structure findings revealed reduced frequency of fine structure components 
in the type-1 diabetes group.  Dhar and Abdala (2007) demonstrated reduced fine 
structure components in adults compared to newborns (both with normal pure-tone 
thresholds), but contributed the difference to maturational changes in the cochlea and 
middle ear.  Wagner et al. (2008) found reduced fine structure number (count) with 
increasing hearing loss.  This loss suggested diminished interaction between the two-
source components. 
The RMS amplitude values were greater in the control group, with the reflection 
component showing the majority of the reduced amplitude in the type-1 diabetes group.  
Mauermann et al. (1999) demonstrated that the reflection component was more sensitive 
to pathology.  This finding suggests that the reduced reflection in the type-1 diabetes 
group may be related to early signs of cochlear pathology or general reduced function.   
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On the other hand, no significant difference between groups in overall phase slope 
was found.  The overall phase slope for the entire frequency range may not be sensitive to 
early cochlear pathology, particularly if the damage is localized.  In addition, no 
difference in change in fine structure frequency count or change in phase with stimulus 
intensity (L2) was found.  The change in fine structure count and phase slope of the 
components is in line with the primary source contributing to the fine structure with 
change in stimulus intensity, L2 .  Basically, as you increase the stimulus intensity the 
contribution from the low-level reflection component diminishes, hence the decrease in 
the fine structure count and the slope of the phase.  Both groups had similar change in the 
response with increased stimulus intensity; the lack of a difference may be due to the 
non-localized nature of the data analysis.  Our analysis of the fine structure count was 
inclusive of the frequency range (f2 =1000-6000 Hz) and we calculated the slope of the 
phase for the entire response (f2 = 1000-11314 Hz).  A future analysis of more discrete 
frequency bands may provide more details. 
The RMS level growth response was greater in the type-1 diabetes participants.  
This may seem like a contradiction, but is consistent with Kummer et al. (1998).  They 
suggested that cochlear pathology resulted in loss of non-linearity.  In other words, 
reduction in of the DPOAE response was greatest at low levels, but smallest at the 
highest stimulus levels such that the growth becomes linearized, therefore, the larger 
growth in response in the type-1diabetes group.  On the other hand the control group had 
stronger low-level responses and saturated at higher levels, resulting in less growth in 
comparison, consistent with compression. 
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The count of fine structure components was shown to decrease with increase in 
stimulus.  The higher number of fine structure in the control group is consistent with their 
larger RMS amplitude from the reflection source, as the phase characteristic (rapid 
change with frequency) of the reflection component contributes greatly to the fine 
structure (and the trend for larger TEOAE and DPOAE responses in controls) (Johnson, 
2010).  The distortion component provides the primary contribution at higher stimulus 
intensities; hence the decrease in fine structure components with increased stimulus level 
and the phase slope remaining around zero.  
In summary, the commonly used clinical protocol OAE (TEOAE and DPOAE) 
methods did not demonstrate a significant difference in OAE responses between the 
control and type-1 diabetes group.  This finding is not surprising as both groups had 
similar pure-tone thresholds and normal middle ear function.  Nonetheless, the type-1 
diabetes group did show a trend for reduced OAEs. This may be due to early indices of 
cochlear pathology or general reduced function. 
The DPOAE fine structure data did show a significant difference in fine 
frequency count, RMS levels (in particular the reflection component), and RMS growth. 
The reduced number of fine structure, lower RMS, and increased RMS growth are 
consistent with expected changes with reduced cochlear function (Mauermann et al., 
1999).   
Our findings support the use of DPOAE fine structure in identifying early signs of 
cochlear pathology.  Also, our method to collect DPOAE fine structure provides an 
efficient method to enable DPOAE fine structure measurements in clinical populations 
not previously feasible due to the time demands of previous methods (Long et al., 2008).  
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We will give further consideration to influence of Covariates and Noise Exposure in their 
respective Chapters VI and VII. 
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CHAPTER V 
 
EFFERENT AND AFFERENT AUDITORY FUNCTION 
 
Literature Review of Efferent Function 
 Efferent auditory function refers to the top-down influence of the central auditory 
system on peripheral auditory function, both sensory and neural. Efferent function has 
been suggested to have roles in protection from acoustic trauma, understanding of speech 
in noise, and localization (Guinan, 2006).  This review focuses on peripheral portions of 
this feedback system, specifically the medial olivocochlear (MOC) pathway.  
 The MOC pathway was first described in detail by Rasmussen in 1946.  Axons of 
the MOC project dorsomedially from the superior olivary complex to Rosenthal’s canal, 
where they travel through the osseous spiral lamina and enter the Organ of Corti.  MOC 
fibers synapse at the base of the outer hair cell (OHC) body and can directly influence 
OHC activity.  The MOC system has been implicated in detection of signals in noise, 
protection from noise damage, selective attention, and OHC gain control. 
Non-invasive assays using OAE responses and auditory brainstem responses 
(ABR) have allowed examination of MOC efferent function in humans.  Briefly, a 
contralateral (opposite to test ear) or forward masked suppressor stimulus (same ear) is 
introduced while the effect on the test stimulus is measured. Only limited work has 
explored neural responses (ABR) as a tool to measure efferent suppression in humans 
(Folsom and Owsley, 1987; Polyakov et al., 1998).  The primary assay in humans uses 
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OAEs.  The interested reader is referred to Guinan (2006) for an excellent review of 
efferent auditory function and methods of OAE suppression.  
All types of OAEs can be used to obtain efferent responses.  The most common 
characteristic is a decrease in amplitude; thus the term suppression is often used.  Berlin 
et al. (1993) presented a method of evaluating suppression with TEOAEs acquired with 
“linear” click stimuli.  TEOAEs were selected due to their wide availability and potential 
ease for clinical application. The linear mode was chosen, as a large portion of the 
suppression effect is linear (Guinan, 2006). In short, efferent suppression of TEOAEs is 
recorded by introducing a suppressor stimulus into the ipsilateral (same), contralateral 
(opposite), or both ears.  A forward masking paradigm is introduced where the suppressor 
stimulus is presented prior to the emission-evoking stimulus and the measured emission 
is compared to conditions without the suppressor stimulus.  Further details are available 
in Hood et al. (1999). 
Diabetes and OAE Suppression.  Only two studies have examined OAE 
suppression in a diabetes population, both in children. Namyslowski et al. (2001) 
reported reduced contralateral suppression of TEOAEs, recorded at 80, 70, and 60 dB 
peak SPL nonlinear clicks, in children with diabetes, aged 6- to 16 years, compared to 
controls, with no differences between groups for TEOAE amplitude. The limitation of the 
study was the use of nonlinear clicks and pure tone stimuli as the suppressor; noise has 
been demonstrated to provide a stronger suppressing effect (Berlin et al., 1993).  
Recently, similar results of contralateral suppression (white noise) of TEOAEs (75-85 dB 
peaks SPL nonlinear clicks) were reported in children with type-1 diabetes (Ugur et al. 
2009).   However, the findings are tempered by the use of a nonlinear stimulus and high 
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intensity of stimulus that may elicit a MEMR and artificially create a reduced emission 
due to a stiffened middle ear.  Neural pathology affecting efferent neural function was 
suggested.   
 
Purpose and Hypothesis 
The purpose of evaluating efferent function was to determine if efferent reflex 
characteristics, and thus a component of neural integrity, are altered in the experimental 
group compared to the control group.  Since reduced efferent strength is believed to have 
implications for susceptibility to hearing loss (Guinan, 2006), we included a measure to 
address the effect of type-1 diabetes on peripheral auditory efferent function using OAE 
suppression.  In addition, no studies have examined ipsilateral or bilateral OAE 
suppression in subjects with diabetes (contralateral suppression is the least robust assay 
of efferent responses; bilateral suppression amplitude is significantly greater; Berlin et 
al., 1995).  
 
Methods 
 Procedures.  TEOAE suppression was measured using the IHS SmartTroae 
system (Miami, FL). Testing was performed in a double-walled sound treated room, 
while the participant was seated in a comfortable chair.  A closed-captioned movie was 
viewable through a window (sound treated) on a monitor in the adjoining room.  
Participants were instructed to sit quietly and try to minimize physiological noise (heavy 
breathing, movement, etc.). TEOAE and suppressor stimuli were presented via two ER 
10D probes inserted in each ear canal using an ER10D foam tip.  The ear with the 
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greatest amplitude for 65 dB peak SPL linear clicks (discussed in the previous section) 
was used as the test ear. 
Effects of binaural and contralateral suppressor stimuli on TEOAEs were assessed 
using a forward-masking paradigm (Berlin et al., 1995).  Broad-band noise (60 dB SPL, 
400 ms duration) preceded click stimuli (75 µsec; 65 dB peak SPL linear click) by 10-
msec (Berlin et al., 1995).   Averages (400) without the suppressor were interleaved with 
conditions acquired with one of the suppressors (binaural and contralateral). At least two 
runs of each condition were measured. Stimulus stability was assessed to assure data 
quality for calculation of MOC reflex strength.  Responses were accepted when both 
stimulus stability in all conditions and OAE reproducibility in the without suppressor 
condition exceeded 70%.  There were approximately 2 noise-click pairs per second and 
400 sweeps were included in each average response.  Therefore, the click rate is much 
slower than the rate for the TEOAEs obtained at 80 and 65 dB peak SPL that were 
discussed in the previous chapter. 
 
Data Analysis 
 The Kresge EchoMaster software was used to analyze the suppression data in a 
time window of 8-18 msec, the time period with the greatest effect (Collet et al. 1990; 
Berlin et al. 1993).  This analysis program allows detailed comparisons of RMS 
amplitude, cross-correlations of the responses, and analysis of time delays (check of 
individual runs and phase consistency).  The two most similar responses for each 
condition (least amplitude and phase difference and highest cross-correlation) were 
averaged.  The average response for the suppressor conditions (bilateral and contralateral) 
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were subsequently subtracted from the without condition to determine amount of 
suppression.  Data with low cross-correlations (>70%) were excluded from the statistical 
analysis.   
All 40 participants were tested, but fifteen participant’s (12 experimental and 3 
controls) data could not be included in the suppression analysis due to low-level TEOAE 
amplitudes in the without condition, leaving 8 matched pairs.  However, as an 
exploratory analysis we examined the response level in the without condition between 
groups.  At least two runs of the without condition were collected in all 40 participants.  
The two without conditions with the least amplitude difference and highest cross-
correlation (phase and amplitude) were averaged and compared between groups. The 
without condition uses a similar 65 dB SPL “linear” click as previously discussed in 
Chapter IV, but at a much slower rate, ~2 clicks per second.  This slower rate is reflective 
of the noise-click paradigm for the suppression conditions. 
 
Statistical Analysis 
 Statistical analysis was performed using SPSS (version 18.0). Data were 
compared between ears and groups using analysis of variance (ANOVA) with p < .05 as 
the criterion for significance. First, noise amplitudes in the response were compared to 
determine if groups had comparable noise floors.  Next, the without suppressor TEOAE 
condition (65 dB peak SPL nonlinear click, ~2/sec) amplitude was compared between 
groups. Finally, the level of contralateral and binaural suppression was compared 
between groups.  
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Results 
 Comparisons between groups for the without suppressor condition (collected on 
all 40 participants) revealed no significant difference for TEOAE amplitude or noise level 
(F = 2.529,  p > .05; F = 1.505, p > .05).  However, as seen with the previous OAE 
results, the experimental group had slightly lower amplitudes in the without condition.  
Despite the lack of a significant difference in amplitude, 12 of the experimental 
participants’ without suppressor responses were too low (< 3 dB SPL) to perform 
suppression, while only 3 controls had levels too low (< 3 dB SPL). Nonetheless, for 
participants with large enough without condition amplitude response (n = 16, 8 matched 
pairs) no significant difference was found for bilateral (F = .219, p > .05) or contralateral 
conditions (F = .069, p > .05); see Figure 3-10. 
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Figure 5-1. TEOAE Suppression Comparison. No significant group effect was 
seen for TEOAE suppression.  Bilateral results are left and contralateral right.  
Mean and SEM are shown.     
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Discussion 
 The lack of a significant difference between groups for the without amplitude 
condition is consistent with the findings at 65 dB peak SPL previously discussed.  The 
without suppressor condition amplitudes were examined due to the high number of type-1 
diabetes subjects that did not meet the criteria for inclusion in the suppression analysis.   
While no significant difference existed between groups for TEOAE suppression, the 
experimental subjects were 4 times more likely to have responses too low in the without 
condition (< 3 dB SPL) to effectively measure suppression.  The influence of covariates 
on this measure and potential interaction in reducing amplitude in participants will be 
discussed in a future chapter.  Both groups demonstrated bilateral and contralateral 
suppression levels comparable to those reported in the literature (Berlin et al., 1995)  
While the two other studies to examine OAE suppression in a diabetes population 
(both in children) found reduced suppression (Namyslowski et al., 2001; Ugur et al., 
2009) we found no difference in TEOAE suppression.  However, both of these previous 
studies used higher stimulus levels and nonlinear clicks that may have confounded their 
findings.  Also the absence of a difference may be related to lack of diabetes related 
complications among the experimental group (no participants reported any neurological 
deficits) and/or the reduced sample size available due to low level responses.   
 
Literature Review of Afferent Function  
 Auditory brainstem response (ABR) testing can be used to objectively record 
neural activity of the auditory pathway at the VIIIth nerve and brainstem level.  By means 
of ABR, it is possible to assess the integrity of neural brainstem generators.  The origin of 
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wave I is the distal cochlear nerve, the wave II is of proximal cochlear nerve origin, and 
wave III is of lower brainstem origin, while the sources of waves IV and V are primarily 
in the mid/high brainstem.  The generated waveforms beyond wave I have multiple 
generator inputs.  An excellent history and recent review of the ABR is available to the 
interested reader in Moeller (2006).  In Figure 5-2 an example of ABR waveforms is 
illustrated. 
 
Figure 5-2.  ABR waveform.  The waves provided correspond to auditory evoked 
brainstem responses.  Waves I, II, III, and V are marked as selected during data 
analysis. 
 
The ABR is used clinically in a number of capacities from determining hearing 
status in newborns to identifying auditory neural pathologies (e.g., vestibular 
schwanomma).  The primary outcomes are amplitude and latency, particularly for wave I 
and wave V and the interwave latency between wave I-V.  Reduced growth of ABR 
amplitude (with increase in stimulus level) can be seen even in the presence of normal 
ABR threshold and has been associated with noise-related pathology of the primary 
auditory afferent fibers (Kujawa and Liberman, 2006).   
ABR rate changes may also contribute to identification of early signs of neural 
brainstem pathology (Gerling and Finitzo-Hieber, 1983; Don et al. 1977).  Neuro-
physiological mechanisms considered to be responsible for amplitude and latency shift 
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with increased rate include reduced cochlear receptor function, decrease in synaptic 
activity, and compromised refractory period.  The normal effect of increased stimulus 
level is increased response amplitude up to a level of saturation.  The normal effects of 
increased rate include reduced amplitude, but minimal change in latency of wave I; and 
for wave V, minimal change in amplitude, but increase in latency (Don et al., 1977; 
Burkard et al., 2007). 
ABR and Diabetes.  Goldsher et al. (1986) examined ABRs in participants (15-55 
years of age) with insulin dependent diabetes mellitus (IDDM), with and without 
peripheral neuropathy, compared to age-matched controls. ABRs were recorded at two 
rates (10/sec and 55/sec) with 75 dB HL clicks.  The participants with neuropathy 
demonstrated prolonged peaks and greater abnormality at the higher rate compared to 
controls particularly for later waves (III and V). Those without neuropathy resembled 
controls in all respects.  Parving et al. (1990) reported prolonged wave V with long-term 
IDDM and presence of microangiopathy. Donald et al. (1981) reported the dominant 
effects of diabetes on wave V findings.  The lack of wave I findings in these studies 
suggests minimal involvement of the distal VIIIth nerve (histological work in humans 
and animals supports minimal VIIIth nerve effects of diabetes, see Appendix A).  
Al-azzai and Mirza (2004) found impaired neural conduction time in both type 1 
and 2 diabetic adults compared to controls, but no difference between types of diabetics 
or duration of disease. However, Bayazit et al. (2000) found that the likelihood of 
encountering a diabetic complication in adults increases as ABR results become 
abnormal.  Vaughan et al. (2007) explored ABR differences in veterans with and without 
diabetes (the type of diabetes was not discussed) and found prolonged wave III and V 
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latencies, but no association with diabetes related clinical characteristics (retinopathy, 
nephropathy, HbA1c, glucose, insulin use, and duration). Virtaniemi et al. (1995) found 
that short-term improvement in metabolic control in diabetic adults had no effect on ABR 
findings.   
ABR disturbances (prolonged latency) have also been described in children with 
IDDM when compared to normative values (Niedzielska et al., 1998).  ABR findings 
have revealed prolonged absolute latencies in adolescent and young adult subjects with 
diabetes compared to age-matched controls, primarily affecting wave V (Durmus et al., 
2004).  
In summary, contradictory findings have been reported on the influence of 
diabetes on ABR latency and amplitude.  The lack of consensus is amplified by the 
inconsistent findings regarding influence of diabetes related variables.  For example, 
Goldscher et al. (1986) found abnormal ABR characteristics in participants with diabetes, 
but only in those with neuropathy.  Other studies have found no relationship to presence 
of neuropathy (Vaughan et al., 2007).  The predominant effects reported in the literature 
were prolonged latency and reduced amplitude in later waves (III and V), while wave I 
(corresponding to the distal VIIIth nerve) was spared. 
 
Purpose and Hypothesis 
The ABR enables evaluation of the auditory nerve and brainstem pathways to 
determine presence of afferent neural dysfunction.  ABR testing was performed to assess 
afferent auditory function in experimental participants compared to controls. We 
examined ABR responses to determine the influence of diabetes on peripheral auditory 
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neural function.   In addition to absolute wave amplitude and latency, we incorporate rate 
effects and growth functions in an attempt to identify early indices of neural damage. We 
did not anticipate significant difference in absolute wave latency or amplitude, but 
hypothesized reduced amplitude growth with increased stimulus level (ABR growth 
function) and reduced amplitude and prolonged latency with increased rate (Rate effects).  
The rationale was based on the ability of these suprathreshold metrics (ABR growth 
function and Rate effect) to identify early signs of neural pathology despite normal 
thresholds (Gerling and Finitzo-Hieber, 1983; Kujawa and Liberman, 2006). 
 
Methods 
Procedures. The IHS smartEP system was used to measure ABR responses.  
Recordings were made in a double-walled sound treated room with the participant seated 
in a reclining chair.  Stimuli were calibrated with the Brüel and Kjaer Pulse system.  
We recorded ABRs using monaurally presented 100 µsec click stimuli (50, 65, 
and 80 dB nHL at 27.7/sec and 77.7/sec, and 2048 sweeps) and standard ABR recording 
procedures (with the exception of increased sweeps/average). The stimulus levels chosen 
fall in the range where the low intensity (50 dB nHL) is above threshold, but would 
demonstration of a change in amplitude with an increase to the highest level (80 dB 
nHL).  The rates selected were based on the findings of Don et al. (1977) that 
demonstrated minimal changes in ABR latency at rates below 30 clicks/sec or beyond 70 
clicks/sec, but large changes from 30 to 70 clicks/sec.   
At least two runs were performed at each level and for each rate to replicate the 
response and rule out artifact (non-repeating peaks).  A rarefaction polarity was used to 
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determine amplitude and latency.  In addition, a condensation polarity was also used to 
rule out artifact, to differentiate cochlear microphonic from neural components, and to 
determine presence of dys-synchrony (if dys-synchrony was observed we would expect 
the rarefaction and condensation responses to be out of phase). The electrode setup 
consisted of a two-channel electrode montage, ipsilateral (Cz-stimulus ear lobe) and 
midline (Cz-Oz) channels (to maximize wave V response amplitude).  The electrode 
impedance was checked at the beginning and end of each ABR session to ensure that 
impedance was less than 5 kΩ and less than 2 kΩ between electrodes. The default band-
pass filter of 100 (high pass) and 3000 Hz (low pass) was implemented. 
 
Data Analysis 
The peaks for wave I, III, and V (only wave I and V were analyzed) were selected 
to determine response peak-to-peak (positive to negative) amplitude and latency. If the 
peak latency and amplitude were inconsistent (absent peak, different latency) the data 
were excluded.  If the two responses replicated the average amplitude and latency of each 
peak was calculated and then averaged.  Two independent reviewers examined the 
responses with comparable findings.    
  
Statistical Analysis 
Statistical analyses were performed using SPSS (version 18.0). Data were 
compared between ears and groups using analysis of variance (ANOVA) and p < .05 as 
the criterion for significance.  Prior to group comparisons, we considered the effect of 
rate and level on wave I and V amplitude and latency.   
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Next, absolute amplitude, latency, and wave I-V inter-wave latency were 
examined between groups.  Additionally, change in absolute amplitudes and latencies 
related to increase in rate and level were considered.  Rate induced changes in amplitudes 
were measured by calculating the difference between amplitude for wave I and V 
(amplitude at 27.7 clicks/sec – amplitude at 77.7/sec).  Rate induced change in wave I 
and V latency were calculated by taking the difference between latency at 77.7 clicks/sec 
– 27.7 clicks/sec for each respective wave.  Rate induced change in the inter-wave 
latency were also examined between groups.  Finally, change in amplitude and latency 
due to increase in stimulus level were compared between groups (80 dB nHL – 65 dB 
nHL for wave I; 80 dB nHL – 50 dB nHL for wave V). 
 
Results 
 Prior to examining group differences we explored some basic characteristics of 
the responses.  First, wave I and V absolute amplitudes at rates 27.7 clicks/sec and 77.7 
clicks/sec were compared at 80 dB nHL.  Wave I showed significant decrease in 
amplitude with an increase in rate (p < .05).  Wave V amplitude did not show a 
significant change with increase in rate.  Next, we considered change in wave I and V 
absolute latency with increase in rate.  Wave V, but not wave I demonstrated significant 
increases in latency with increase in rate.  In addition there was a significant increase in 
the inter-wave I-V latency. The change in inter-wave latency was related to the four times 
larger change in wave V latency compared to that of wave I.  Figure 5-3 illustrates the 
change in latency and amplitude with change in rate. 
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Figure 5-3.  ABR Latency and Amplitude Rate Effects.  We depict the change in 
latency (grey) and amplitude (black) with change in rate for wave I and V.  It is 
clear that there is a greater change in latency for wave V and greater change in 
amplitude with wave I.  This finding is consistent with known rate effects in the 
literature (reviewed by Burkard et al., 2007).  Mean and SEM are shown. 
 
 
 The expected changes in latency and amplitude were observed related to level and 
rate effects.  However, we found no significant difference between the experimental and 
control group for the following: absolute latency and amplitude, interwave I-V latency, 
change in amplitude and latency with increased rate, or change in amplitude and latency 
with increased level.  In summary, both groups displayed similar ABR findings for both 
wave I and wave V.  See tables in Appendix B. 
 
Discussion 
 Our study demonstrated no significant difference for ABR responses between the 
experimental group and controls. Our findings are consistent with those reported in the 
literature in subjects without impaired neural function (Goldsher et al., 1986; Parving et 
al., 1990). While we did not expect differences in absolute wave amplitude and latency, 
our hypothesized rate and growth function effects were also absent.  This is likely related 
to the lack of diabetes related complications associated with neural dysfunction in our 
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sample; no participants reported history of neuropathy, retinopathy or nephropathy.  
While it is possible that type-1 diabetes can lead to impaired auditory neural function, the 
primary findings in histopathological studies support a dominantly cochlear pathology 
(see Appendix A).   
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CHAPTER VI 
 
COVARIATES 
 
Literature Review 
 A number of covariates have been proposed to influence the relationship between 
diabetes and hearing loss.  These include: sex, age, noise exposure (explored in the next 
section), and diabetes variables (cardiovascular health, duration of diabetes, severity of 
diabetes, method of treatment, neuropathy, nephropathy, and retinopathy).  Reports exist 
that both support and challenge most of these covariates.   
Sex. The influence of sex on susceptibility to hearing loss has been revisited many 
times over the years.  The common finding is that males generally have greater 
susceptibility to age-related hearing loss (Glorig and Nixon, 1960; Gates et al., 1990) and 
noise induced hearing loss (reviewed in Henderson et al., 1990).  However, a gender 
reversal has also been noted, where females have greater loss at frequencies below 1000 
Hz, while males have greater loss above 1000 Hz (Jerger et al., 1993).  It is unclear 
whether these are inherent biological differences or merely a reflection of differences in 
lifestyle.  Indeed, Rosen et al. (1962) explored thresholds in a population relatively free 
of any noise exposure and found that males and females showed no differences in high 
frequency thresholds.    
Despite the audiometric contradiction, studies of TEOAEs and DPOAEs routinely 
show diminished responses in males compared to females.  This finding is seen both in 
newborns (limiting confounds of noise exposure), adults, and animal models.  
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Interestingly, TEOAEs show greater reduction than seen in DPOAEs.  This difference 
has been attributed to external/middle ear difference and/or modulation by some 
biological factor, such as androgens (McFadden, 1999) or efferent function (Velenovsky 
and Glattke, 2002) on the linear reflection mechanism, while the nonlinear distortion 
mechanism is relatively unaffected (McFadden et al., 2009). Only one study has 
examined the influence of sex on DPOAE fine structure.  The results demonstrated no 
difference in frequency of fine structure, but larger depth and spacing in females (Dhar 
and Abdala, 2007). ABR findings have also suggested shorter latencies in females 
compared to males, even after control for differences in head size.  A shortened and 
stiffer cochlea in females has been proposed to explain this difference (Edwards et al., 
1983; Don et al., 1993).  
Sex differences in type-1 diabetes factors are believed to be fairly minimal.  Most 
studies have reported equivocal metabolic control, though some studies have found 
higher HbA1c levels in young females compared to males, and an influence of endocrine 
changes has been speculated (Hochhauser et al., 2008).  Nonetheless, the understanding 
of physiological differences between the sexes and their influence on diabetes is limited. 
The effect of sex on auditory function in persons with diabetes also remains 
unclear.  Tayor and Irwin (1978) reported significantly poorer thresholds in females with 
diabetes compared to males.  Dietzel et al. (1964) found the opposite results, while 
Cullen et al. (1993) reported that males displayed elevated thresholds. Axelsson and 
Fagerberg (1968), Ray et al. (1995) and El-Tabal et al. (2003) found no sex effect.  
Ottaviani et al. (2002) reported that females had significantly higher TEOAE amplitudes 
compared to males in both control and experimental participants.  However, they did not 
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describe the relationship in any detail. ABR findings have shown that males with diabetes 
have prolonged latency compared to females with diabetes, but not significantly different 
than male controls, which may or may not have been correlated with cochlear or 
head/brain size difference (Pudar et al., 2009).  
 Age.  It is well known that hearing loss increases with age.  However, findings 
regarding the influence of age on the relationship between diabetes and hearing loss has 
been mixed.  Many early studies found greater loss in older adults with diabetes, however 
most of these studies did not have age-matched controls nor control for other covariates 
such as noise exposure, ototoxic drugs, etc (Fowler and Jones, 1999).  Kurien et al. 
(1989) reported significantly elevated high frequency thresholds in all age groups.  A 
significant correlation of pure tone thresholds with diabetes and age was demonstrated by 
Ferrer et al. (1991).  El-Tabal et al. (2003) showed no relationship between diabetes and 
age for participants less than 40 years of age.  
Recent large scale epidemiological studies have suggested that diabetes is related 
to an early onset of hearing loss, showing elevated pure tone thresholds at younger ages 
compared to controls (Vaughan et al., 2005; Bainbridge et al., 2008; Austin et al., 2009). 
The diminished difference with age was attributed to competing causes that accumulate 
over a lifetime and narrow the gap.  This provides a partial explanation for why previous 
studies that looked at the relationship between diabetes and hearing loss in older adults 
have found contradictory findings. Another reason is that metrics were limited to pure-
tone thresholds and not inclusive of other sensitive metrics like OAEs and extended high 
frequencies testing. 
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Diabetes Variables.  The influence of diabetes related covariates also have 
contradictory findings. Tay et al. (1995) demonstrated elevated hearing thresholds with 
longer duration of diabetes, but no relationship with retinopathy.  On the other hand, 
Cullen et al. (1993) found no relationship of hearing thresholds with duration, insulin 
dosage or family history.  Another study of participants with type-1 diabetes found a 
relationship with duration of disease and retinopathy, but not with neuropathy, HbA1c, or 
hypoglycemic episodes (Ferrer et al., 1991). 
Di Leo et al. (1997) and Di Nardo (1998) found reduced TEOAE amplitudes in 
diabetic participants with reduced nerve conduction velocity (NCV), but not in diabetic 
participants with normal NCV. DPOAEs were reduced in both patients with NCV and 
without NCV.  No associations were for duration of diabetes, HbA1c values (single 
measure at time of testing) with either TEOAEs or DPOAEs.  These researchers 
contributed the changes in OAE amplitudes to microvascular compromise, despite no 
measurement for presence of microangiopathy. Lisowska et al. (2001) found similar 
results with DPOAEs in normal hearing young adults with type-1 diabetes. They reported 
no relationship to the presence of microangiopathy (evaluated by opthalmoscopy and 24 
hour albumin excretion rate), finding altered responses in both patients with 
miroangiopathy and without. Ottaviani et al. (2002) found significant differences between 
persons with type-1 diabetes compared to controls (not matched) for both TEOAE and 
DPOAE amplitudes, but no relationship was demonstrated with duration of disease, 
HbA1c, mean daily insulin dose, micoralbuminuria, and presence of neuropathy.  This is 
the first study to examine DPOAE fine structure and type-1 diabetes. 
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Goldsher et al. (1986) described prolonged ABR latency in IDDM patients with 
neuropathy, but not in IDDM patients without neuropathy. Bayazit et al. (2000) reported 
an increase in diabetic complications with abnormal ABR results. A study in children (8-
21 years) found no significant differences between diabetes and control groups or a 
relationship with control (maintenance of diabetes) or presence of neurological or 
vascular complications (Sieger et al., 1983).  
 
Purpose and Hypothesis 
The literature review described highly variable findings related to the influence of 
sex, age, and diabetes factors on auditory function.  The purpose of the covariate analysis 
was to determine the influence of these covariates on the outcome measures.  We do not 
expect an age effect, simply due to the use of a younger population.  There may be some 
inherent sex differences, particularly in OAEs and ABR responses (as described in the 
literature review).  We also consider the influence of diabetes factors in potentially 
exacerbating or mitigating findings.   We hypothesized that “poorer” maintained diabetes 
would demonstrate poorer outcomes, while “better” maintained diabetes participants 
would have similar function as the control participants. 
 
Methods 
 Procedures and Analyses.  The individual procedures for each auditory function 
measure were described previously in their respective sections.  Data on sex, age, and 
diabetes variables (duration, average HbA1c, episodes of poor control, self-control rating, 
physicians-control rating, number of complications/co-morbidities) were obtained 
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through an interviewer-administered questionnaire (see Appendix C for full 
questionnaire).  The questions included were based on those asked in the SEARCH study 
(SEARCH, 2007) and suggested by an expert in diabetes (William Russell, MD). The 
participant’s previous five glycated hemoglobin levels (HbA1c) were acquired (with 
consented permission) from the participant’s health care provider.  We were unable to 
access HbA1c findings for one of the experimental participants. 
In addition to examining these independent covariates, the experimental group 
was separated into two additional groups by ranking degree of “control” of diabetes.  The 
degree of “control” was determined with consideration of HbA1c levels, episodes of poor 
control, self and physician rating (as rated by the participant, asked “how would your 
doctor rate your diabetes control”), and presence of complications.  Participants’ 
“control” was categorized as “poorer control” based on the sum of these criteria: average 
HbA1c > 7.5%, self or physician rating was < good (fair or poor), participant reported 
episodes of poor control, and if they reported diabetes related complications (see Table 1 
in Chapter II).  The experimental participants were then ranked, those with the greatest 
frequency of these criteria were placed in the group “poorer control”, while the 
participants with the lowest frequency were considered to have “better control”.  Figure 
6-1 shows the separation of better and poorer control compared to Average HbA1c levels.  
The overlap region is related to contribution of other factors such as self-control rating, 
reported poor control, and number of diabetes related complications.  Sex of the 
participant was not a determining factor in determining “control”. 
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Figure 6-1.  Derived Diabetes Control by HbA1c.  This figure shows the 
separation of type-1 participants into levels of control compared to Hba1c.  The 
overlap reflects weighting from self and doctor-control rating, reported poor 
control, and number of diabetes related complications. Note that data were not 
available for one participant. 
 
  
The statistical analysis started with Spearman rho correlations; comparing the 
auditory function measures with age and the diabetes related covariates (independent 
variables listed above and the derived “control” of diabetes). The sexes were compared in 
regards to age, auditory function measures and diabetes variables using ANOVA and chi-
square.  All statistical analyses included the significance criteria, p < .05.   
 
Results 
 No significant correlations were found for age or diabetes related covariates with 
any auditory function outcome.  No significant difference was observed between males 
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and females in terms of age, pure tone thresholds (PTAL, PTAH, PTAE), or amount of 
TEOAE suppression (bilateral or contralateral).  Significant differences were present for 
the without condition (65 dB peak SPL clicks presented at the slower rate).  Significant 
findings were also found for TEAOE amplitudes at both 80 dB peak SPL and 65 dB peak 
SPL (regular rate).  In addition, DPOAE findings were significantly different between the 
sexes.  In all instances of significant findings females demonstrated greater OAE 
amplitudes than males.   
DPOAE fine structure results also revealed significant differences between sexes 
related to RMS level; however, the number of fine structure components (count) and 
phase slopes were not different.  Also, change in RMS, fine structure count, and phase 
slopes with increase in stimulus intensity (L2) were not significantly different between 
sexes.  Finally, a number of ABR amplitude and latency differences were indicated.  
Again, females demonstrated greater amplitudes and shorter latencies in all instances.  
Tables 6-1 (OAEs), 6-2 (ABR), and Figure 6-2 (Fine Structure) provide a summary of the 
significant sex differences for auditory function outcomes determined by ANOVA at p < 
.05. 
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Table 6-1.  ANOVA for Otoacoustic Emission Amplitudes and Sex.  The 
significant correlations between OAE response amplitudes (dB SPL) and sex (M 
= male, F = female) at p < 0.05 are provided.  In all instances the direction is for 
greater amplitude and smaller latency in females.   
 
OAE Measures Mean M Mean F SEM M SEM F F 
TEOAE 65 dB 19.3/sec .5878 6.0032 1.31 .831 13.037 
TEOAE 80 dB 19.3/sec 15.6275 18.8559 .853 .496 11.656 
     1000 Hz -8.9781 -5.1677 1.18 .765 7.824 
     1500 Hz -13.5744 -8.1136 1.39 .824 12.368 
     2000 Hz -19.2600 -14.4764 1.09 .999 10.365 
     3000 Hz -21.1800 -16.3155 1.19 1.18 8.271 
     4000 Hz -22.5997 -17.2752 .869 .967 16.068 
TEOAE 65 dB ~2/sec 3.3645 7.0167 1.13 .649 8.566 
DPOAE 592 6.9167 10.2727 1.23 .923 4.941 
DPOAE 701 8.3611 12.4545 1.57 .871 5.695 
DPOAE 841 10.4722 13.7273 1.01 .881 5.931 
DPOAE 997 9.5278 13.4318 1.18 .630 9.425 
DPOAE 1199 7.1944 11.8636 1.17 .827 11.179 
DPOAE 1401 6.8611 9.8864 1.19 .827 4.616 
DPOAE 1666 5.5556 8.9545 .888 .769 8.449 
DPOAE 1977 2.6111 4.40105 1.04 .712 14.778 
DPOAE 2382 .3056 4.3636 1.17 .724 9.314 
DPOAE 2834 -2.1667 5.2955 1.81 .808 16.128 
DPOAE 3379 2.4722 9.9773 1.81 1.33 11.557 
DPOAE 4002 .5833 7.8636 2.23 1.90 6.263 
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Figure 6-2.  Fine Structure RMS Amplitudes by Sex. The figure presents the RMS 
for each group at the three different L2 levels tested across the center frequency of 
2f1-f2.  The top left illustrates the RMS for the overall fine structure, the top right 
the distortion component, and the bottom center the reflection component. The 
RMS for top right, top left, and bottom center are reduced in males.  However, the 
growth of RMS is not significantly different.  This indicates that the non-linear 
function is conserved in both males and females overall. Mean and SEM are 
shown. 
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Table 6-2.  ANOVA for ABR and Sex. The significant ANOVA findings between 
ABR latency (msec) and amplitude (µv) and sex at p < 0.05 are provided.  In all 
instances the direction is for greater amplitude and smaller latency in females.   
 
ABR Outcomes Mean M Mean F SEM M SEM F F-test 
Wave I lat @ 108 27.7 1.7389 1.6601 .032 .020 4.561 
Wave V lat @ 108 27.7 5.9853 5.7365 .043 .039 18.031 
Wave V lat @ 93 dB 27.7 6.4072 6.1160 .053 .041 19.347 
Wave V lat @ 78 dB 27.7 7.080 6.5917 .084 .055 25.030 
Wave I lat @ 108 dB 77.7 1.9125 1.6949 .075 .036 7.599 
Wave V lat @ 108 dB 77.7 6.3961 6.1504 .057 .047 11.193 
Wave V lat @ 93 dB 77.7 6.9201 6.5904 .075 .049 13.994 
Wave V lat  @ 78 dB 77.7 7.5888 7.0918 .084 .054 25.564 
Wave I lat Δ in rate @ 108 .2114 .0379 .070 .027 6.295 
Wave I-V lat @ 108 dB 27.7 4.2464 4.0764 .049 .048 6.029 
Wave I amp @ 108 27.7 .2456 .3422 .017 .022 11.535 
Wave V amp @ 108 27.7 .3549 .4798 .026 .033 8.365 
Wave I amp @ 108 dB 77.7 .1258 .2253 .014 .033 6.593 
Wave V amp @ 93 dB 77.7 .2951 .3681 .019 .017 8.153 
Wave V amp Δ in rate @ 108 -.0171 .0658 .024 .023 6.061 
Wave V amp growth @ 27.7 .0617 .1680 .028 .024 8.235 
 
  
Despite the observed difference in auditory function between males and females, 
no significant findings related to sex were indicated for diabetes variables.  Both males 
and females demonstrated similar HbA1c levels, frequency of complications, and control 
(reported and derived).  Table 6-3 and Figure 6-3 summarize the male and female 
diabetes related variables, no significant differences were seen at p < .05. 
 
Table 6-3.  Male vs. Female Diabetes Control.  No significant difference in 
diabetes related variables was found using ANOVA, p < .05. 
 
Diabetes Variables Mean M Mean F SEM M SEM F 
HbA1c 7.12 8.33 .284 .589 
Duration (years) 8.44 9.18 2.21 2.03 
Complications Frequency .778 .455 .132 -.097 
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Figure 6-3.  Control by Sex.  Both males and females showed similar frequency of 
“better” and “poorer” control status. Chi-square between sexes was not 
significant, p < .05. 
 
 
Discussion 
 The influence of covariates related to age and diabetes characteristics were 
minimal.  This is not surprising given the young age of the sample and lack of significant 
auditory function findings between type-1 diabetes and controls.  Most diabetes related 
complications increase in incidence with increasing duration of disease (Sieger et al., 
1983), the younger age and minimal report of complications may have precluded 
identification of a relationship with our diabetes related variables.  This is in line with 
early findings of Rosen and Davis (1971); they found no correlation between severity of 
microangiopathy and degree of hearing loss in participants with diabetes below the age 
25 years.   
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While, no sex differences were found for the basic audiological findings (PTA 
and immittance results), differences were revealed for TEOAEs, DPOAEs, and ABR 
latency and amplitudes.  These findings are consistent with the reviewed literature, where 
females demonstrated stronger OAEs and ABR responses compared to males.  Potential 
explanations for these differences include genetic predisposition, biomolecular function 
(e.g., influence of androgens during development), cochlear characteristics (e.g., size and 
stiffness), lifestyle influence, and level of noise exposure (see Chapter VII titled Noise 
Exposure).  
 Previous work has demonstrated influence of diabetes-related complications and 
characteristics (HcA1c, duration, control, etc.) on pure tone thresholds, OAEs, and ABR 
findings.  However, we did not find any significant trends or influence of these covariates 
on our findings.  This may be partially explained by the lack of diabetes-related 
complications, young age of the participants in this study, higher average socioeconomic 
status, care being provided by a top rated medical center, and good control among our 
sample.  
Finally, we did not find any significant differences between males and females in 
regards to diabetes characteristics. Males and females demonstrated similar duration, 
HbA1c levels, frequency of complications, and reported/derived control. 
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CHAPTER VII 
 
NOISE EXPOSURE 
 
Literature Review 
 The literature on noise exposure or acoustic overexposure is immense.  Noise 
exposure in this study refers to exposure to all sources of “loud” sounds including 
occupational and recreational sources.  The literature supports occupational sources as the 
primary factor contributing to noise-related hearing loss (NRHL).  However, much recent 
work has found greater influence of recreational sources in directly causing NRHL or 
exacerbating the effects of occupational noise exposure by diminishing recovery time.  
Maassen et al. (2001) provide an excellent review on influence and interaction of 
recreational noise sources.   
The literature on the susceptibility of persons with diabetes to NRHL is minimal.  
In this review we consider the influence of covariates (analyzed in the previous section) 
on susceptibility to NRHL (sex, age, and diabetes) and the ability of our outcomes to 
identify early signs of noise-related damage.  In Appendix A we speculate on underlying 
mechanisms that may contribute to exacerbated risk of NRHL in the diabetes population. 
 Sex.  It is generally accepted that males develop greater high frequency hearing 
loss than females with age.  A common factor believed to contribute to this difference is 
greater exposure to damaging levels of sound.  Indeed, several studies have demonstrated 
that males tend to have higher and more frequent exposure to loud sounds from both 
recreational, occupational, and military sources (Serra et al., 2005; Helfer et al., 2010). 
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While frequency of encounter with noisy sources has traditionally been higher in 
men, the exact influence of sex is less known.  Boettcher (2002) found no indication that 
sex exacerbated risk of NRHL in the gerbil. Willott (2009) examined the influence of sex 
and gonadal hormones on susceptibility to NRHL in C57BL/6J mice.  The results 
indicated that ovarian hormones increased risk of low-frequency hearing loss in females. 
This difference might be explained by changes in hormones with maternal response to 
pups; these high frequency demands may diminish the importance of low frequency 
hearing and allocate less protection to this region.  McFadden et al. (1999, 2000) reported 
that female chinchillas incurred more high frequency NRHL than males, but the opposite 
was true at low frequencies. However, human studies of higher levels of estrogen and/or 
progesterone have demonstrated protective effects in reducing susceptibility to hearing 
loss (Kilicdag et al., 2004; review by Hultcrantz et al., 2006).  
Human research has also demonstrated higher low frequency thresholds in 
females compared to males, while males have greater high frequency thresholds than 
females (Moscicki et al., 1985; Jerger et al., 1993). In general, experimental studies of 
TTS in humans have found that males exhibit more TTS than females from low-
frequency exposures (below 2000 Hz), whereas females exhibit more TTS than males 
from high-frequency exposures (above 2000 Hz) (as reviewed by McFadden et al., 1999; 
Ward, 1966).  
Data regarding sex effect on NRHL in humans varies.  Several studies suggest 
that males may be more susceptible than females, whereas others do not support such a 
conclusion (as reviewed by Boettcher, 2002 and Henderson et al., 1993).  Again, the 
contribution of physiological differences vs. environmental contributions to differential 
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susceptibility remains unclear.  However, efferent function has been demonstrated to be 
stronger in women than in men (as reviewed by Velenovsky and Glattke, 2002) and along 
with hormonal differences may reflect differences in susceptibility.  Even if similar noise 
exposures exist between men and women, there are other health and lifestyle differences 
between men and women that can play a role (e.g., disease, diet, etc.). 
 Age.  The effect of age on susceptibility to hearing loss in general also has 
received a great deal of attention with contradictory findings.  However, it does seem that 
noise exposure increases dramatically from childhood to young adult ages (Maassen et 
al., 2001; Biassoni et al., 2005).  Greater independence contributes to increased 
opportunity for exposure to both recreational (e.g., concerts, bars, clubs, car stereo) and 
occupational sources. 
The study of influence of exposure age on susceptibility to NRHL also reveals 
contradictory findings.  Boettcher (2002) examined the influence of age on susceptibility 
to acoustic trauma in gerbils.  Animals were exposed as either young adults (6-8 months) 
or near the end of the average lifespan (34-38 months).  The degree of NRHL was similar 
for each group, suggesting no difference for susceptibility to hearing loss.  Fraenkel et al. 
(2003) found no difference in threshold shift for young and old rats with ABR and OAEs.  
Sun et al. (1994) reported that aged chinchillas incurred similar amounts of hair cell loss 
from noise as younger chinchillas, while McFadden et al. (1997) reported that older 
chinchillas had more hair cell loss, but similar thresholds.  Miller et al. (1998) exposed 
young and aged CBA/J mice with similar pre-exposure thresholds to noise and reported 
that aged animals were more susceptible to thresholds shifts and hair cell loss.  
Meanwhile, studies in guinea pigs and cats have indicated that young animals are more 
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susceptible to noise induced damage (Jauhiainen et al., 1972; Price, 1976).  More 
recently, Kujawa and Liberman (2006) demonstrated that animals exposed earlier in life 
had greater threshold shifts when measured at 2 weeks post exposure and greater degrees 
of neural degeneration with age.  Other earlier animal studies have reported a sensitive 
period of noise susceptibility early in age (Bock and Seifter, 1978; Lenoir et al., 1979; 
Henry, 1984 as reviewed by Henderson et al., 1993). 
 Few studies have examined differential susceptibility to NIHL due to age in 
humans, particularly incorporating both children and adults.  Those that have also 
revealed contradictory results with some suggesting increased susceptibility in younger 
participants, some reporting increased risk in older participants, and others no difference 
(as reviewed by Siervogel et al., 1982; Hetu et al., 1977).  First, the physiological 
difference in susceptibility would be difficult to estimate based on age alone without 
consideration of noise history and other factors.  Older participants have had a lifetime 
for potential exposure to noxious noise stimuli, which would be less in younger 
participants.  However, studies have shown that efferent function strength may affect 
susceptibility to NIHL, matures over time in newborns, and diminishes with older age 
(Moore et al., 1999; Zhu et al., 2007).  These relative changes in efferent function suggest 
increased risk for NRHL in the youngest and oldest age groups.   
Second, we must also consider the environmental element.  To accurately, 
examine the differential susceptibility to hearing loss, the noise exposure would have to 
be similar (as well as other history).  It is more likely that young adults and adults of 
working age will be exposed to occupational noise that has been associated with 
increased risk of hearing loss than children, who likely are limited to recreational sources 
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of noise exposure.  Recreational sources of noise have been indicated as having a variable 
amount of influence on NRHL, however firearms use has consistently demonstrated 
increased risk (Neitzel et al., 2004; Clark, 1991).   
The question remains if the age of humans physiologically influences risk for 
NRHL.  If one could take a child and adult with low noise exposure history, control 
genetic and other risk factors (smoking, medical health, lifestyle, etc.), and then expose 
them to a noise to look at TTS, it might be possible to get a glimpse at physiological 
susceptibility.  This author was unable to find such a study with these stringent 
constraints; however, a study by Hetu et al. (1977) found no difference between 12 year 
olds and adults for TTS after exposure to a broad-band noise.   
 Diabetes.  Very few epidemiological studies have examined diabetes and 
susceptibility to NRHL.  Most human studies have excluded or controlled for noise 
exposure, while a few have considered it as an independent factor contributing to 
variance in auditory function (e.g., Dalton et al., 1998).  Vaughan et al. (2005) performed 
a 5-year prospective study of diabetes and hearing loss.  Pure tone threshold testing 
revealed an interaction between noise, age, and diabetes.  However, the high level of 
noise exposure among all controls and diabetes groups limited the ability to draw 
conclusions on differences in susceptibility to NRHL.   
Two human clinical studies have specifically examined diabetes (type not 
indicated) as a risk factor for NRHL.  Both studies were performed in adults with 
occupational noise exposure.  Hodgson et al. (1987) found no evidence of poorer hearing 
thresholds in participants with diabetes than control participants with similar noise 
exposure levels.  However, Ishii et al. (2003) studied NIDDM and noise exposure and 
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found that persons with NIDDM were more likely to develop severe NRHL than those 
without NIDDM.    
Controlled animal experiments have demonstrated a more significant loss of outer 
hair cells (OHCs) in noise exposed rats with diabetes compared to noise exposed 
controls, but without consideration of molecular mechanisms and relationship to glucose 
metabolism (Smith et al., 1995; Raynor et al., 1995).  McQueen et al. (1999) found 
significant basement membrane thickening of the cochlea (microangiopathy) in rats with 
NIDDM, however only in the combination with obesity and/or exposure to noise.  Wu et 
al. (2009) found that rats with diabetes demonstrated impaired recovery from a noise 
induced temporary TTS, and that recovery was improved to control levels with insulin 
treatment.  An expanded review is provided in Appendix A. 
 Outcome measures.  The traditional clinical indication of NRHL is a “notched” 
audiogram. A noise-notch typically means thresholds at 3000, 4000, and/or 6000 Hz that 
are substantially worse than thresholds at lower and higher frequencies.  This is related to 
the resonant frequency of the external and middle ear, which gives greatest emphasis to 
frequencies around 2700 Hz and the half octave shift of the inner ear region of maximal 
excitement (Rosowksi, 1991; Cody and Johnstone, 1981).   
In contrast the audiogram of pure age-related hearing loss is typically down-
sloping with progressively worsening threshold in the higher frequencies (as reviewed by 
Rabinowitz et al., 2006).  The noise-notch is not an absolute evidence of noise damage; 
other factors can also contribute to notched audiograms. However, notches present in 
younger subjects may provide good evidence of noise exposure (Gates et al., 2000). 
Extended high frequency audiometry may also serve as an early predictor of NRHL 
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(Fausti et al., 1981). This is consistent with animal work showing early signs of acoustic 
overexposure in the “hook” of the cochlea (extreme base) (Wang et al., 2002).   
Otoacoustic emissions may show changes prior to even any change in threshold.  
The changes can include reduced amplitude and changes in response growth (Attias et al., 
1995; Lucertini et al., 2002; Sisto et al., 2007).  Strength of efferent suppression may 
have a role in protection from NRHL, however the direct influence of loud sound on the 
efferent system itself is unknown.  Kujawa and Liberman (2006) demonstrated that mice 
exposed to moderate levels of noise exposure experienced changes in suprathreshold 
ABR amplitude (reduced growth related to primary loss of afferent neural fibers of the 
auditory nerve) despite normal ABR thresholds.  The loss was further confirmed with 
histological analyses. 
In summary, a number of factors may influence susceptibility to NRHL.  The 
relationship between NRHL and diabetes has received limited study in both human and 
animal populations, but the findings thus far indicate some elevated susceptibility to 
damage.  In this section we consider the relationship between diabetes and noise exposure 
history.   
 
Purpose and Hypothesis 
 The purpose of this section of the study was to examine the interaction between 
noise exposure history and type-1 diabetes.  To uncover the relationship we have 
performed an in-depth retrospective history of noise exposure and include the most 
sensitive auditory function metrics available (discussed in their respective sections).  
Based on previous work we hypothesize that persons in the experimental group with 
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higher noise exposure will have greater damage compared to those with lower noise 
exposure and more so than controls.  In addition, we will determine if noise exposure is 
an independent factor contributing to greater degree of hearing loss in persons with 
diabetes.  Exacerbated susceptibility to NRHL may help explain the recent 
epidemiological findings for early onset of hearing loss in younger persons with diabetes.  
For the interested reader a biomolecular basis of our hypothesis is reviewed and 
presented in appendix A. 
  
Methods 
 Procedures.  Noise exposure history and other noise exposure information were 
obtained through interviewer-administered questionnaires to estimate frequency, duration 
and subjective level of daily noise exposure from recreational and occupational sources.  
Noise exposure estimates were used to classify each participant into categories of  
“higher” or “lower” exposure to dangerous levels of noise.  
Responses to three questionnaires were selected to examine noise exposure. These 
particular questionnaires were chosen to account for recent- and life-long exposure to 
potentially damaging sources and levels of sound.  These type of questionnaires have 
been the most commonly used to examine noise exposure in younger populations 
incorporating recreational sources. The first questionnaire was a modified version of a 
noise exposure history used by Seixas et al. (2004) with components from a history 
developed by Neitzel et al. (2004a, 2004b).  We will subsequently refer to these items as 
the noise exposure history (NEH).  The second questionnaire was a General Noise 
History (GNH) based on the work of Jukitulppo et al. (1997; 2006).  The GNH provided 
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a retrospective estimate of noise exposure during an average week over the past few 
months, with consideration of frequency, duration, use of hearing protection, and 
subjective loudness (using a five-item Likert scale).  The third questionnaire was the 
Adolescents’ Habits and Hearing Protection Use (AHH) (Olsen-Widen and Erlandsson, 
2004; Holmes et al., 2007). The AHH was presented in a modified form to elucidate an 
estimate of noise exposure over the participant’s lifetime. Approval was received from 
the authors of these questionnaires for their use in this study.  The questionnaires, 
instructions, and further details are located in Appendix C.  Prior to this study, all of the 
questionnaires were piloted in a group of Ph.D. graduate and high school students to 
determine wording, variable inclusion, and ease of use. 
 
Data Analysis   
The frequency, duration, use of hearing protection and subjective loudness of 
noise exposure were considered.  The GNH and AHH, in addition to the total number of 
noisy activities and subjective response to level of exposure to loud sounds (NEH) were 
used to determine the participant’s total noise history (TNH).    In the GNH, noise 
exposures with subjective ratings (sr) of > 3.5 were multiplied by the number of days per 
week (dw) and number of hours per day (hd) and summed, GNH = ∑ (sr x dw x hd).  For 
the AHH, the frequency of participation in 14 noisy environments was evaluated.  A 
weighting was applied to frequency of participation (1=never, 2=seldom, 3=sometimes, 
4=often) and summed.  The participant’s were then ranked on their GNH and AHH 
scores (0 = lowest, 1 = mid level, 2 = highest level).  The TNH was calculated as the sum 
of the GNH and AHH rankings plus the following from the NEH: the total number of 
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noisy activities performed on a regular basis, musician training, work in a noisy 
environment and gun/hunting use (from the NEH).  An extra point was added to the 
overall TNH for each activity noted on the NEH.   
The NEH revealed few participants were exposed to high levels of noise at work 
(n =4).  All but one participant reported owning a personal listening device (MP3 player, 
iPod, etc.).  The average weekly use of personal listening devices is presented in Figure 
7-1.  
0-1 hrs
2-4 hrs
5-8 hrs
9-15 hrs
> 15 hrs
 
Figure 7-1.  Personal Listening Device Weekly Use.  The overall average weekly 
use in hours for personal listening devices use.  The majority of participants used 
their device 4 hours or less per week. 
 
 
The mean level setting for personal listening devices (based on a loudness scale 
corresponding to number of increments on an iPod, ~16 clicks reaches maximum output 
level) in quiet was 6.26 (SEM ± .505) and in noise 11.41 (SEM ± .415). Only one 
participant reported having continuous tinnitus.  Twenty-six participants indicated never 
or rarely experiencing a change in hearing when exposed to loud sounds (transient 
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tinnitus, aural fullness, pain, etc.).  Table 7-1 summarizes activities reported that were 
performed on a weekly basis at some point in the participant’s life.  
 
Table 7-1.  Noise Exposure History Noisy Activity Participation.  The percentage 
of participants that indicated that they partake in a selected activity on a weekly 
basis at some time in their life. 
 
 
 
 
 
 
 
 
 
Finally, participants were asked to report their subjective rating of lifetime 
exposure to loud sounds, Figure 7-2 provides a summary.   
 
Noisy Activity % Yes 
Musician/Music Instrument 60 
Carpentry 7.5 
Metal Work 5 
Chainsaw 2.5 
Other Power Tools 12.5 
Motorsports (motorcycle, boating, etc.) 12.5 
Concert Attendance 20 
Bar/Club 75 
Gun/Hunting 2.5 
Construction Work 0 
Factory Work 2 
Mechanic Work 0 
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Figure 7-2.  Lifetime of Noise Exposure Rating.  This figure illustrates the 
reported lifetime of noise exposure in the sample.  The majority of participants 
reported moderate to low levels of noise exposure. 
 
 
 
Figure 7-3 and Tables 7-2 and 7-3 provide summary descriptives for the GNH, 
and AHH responses.  
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Figure 7-3.  General Noise History Activity. This figure illustrates the hours per 
week of participation in different potentially noisy activities.  To the right is the 
number of participants that reported performing the activity.  Few participants 
reported louder activities such as motorcycle, power tools, playing in a band, 
hunting/gun shooting. Mean and SEM are shown. 
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Table 7-2.  General Noise History Loudness and Hearing Protection Use.  This 
table provides the mean subjective rating of loudness level (1 =  quiet, 2 = 
somewhat quiet, 3 = noticeable, 4 = loud, 5 = very loud).  In addition, the number 
of participants that reported using a hearing protection device (HPD) while 
performing the activity.  The loudest activities were hunt/gun, concert attendance, 
and playing in a band.  Very few participants reported HPD use except for the 
hunt/gun activity.  No participants reported recent activity in the list of activities 
at the bottom of the table. 
 
Activities n Mean SEM HPD 
TV 40 2.31 .081 0 
Indoor Home Care 29 2.83 .143 0 
Lawn Care 7 3.86 .143 2 
Phone Use 39 2.19 .057 0 
Car 40 2.59 .071 0 
Motorcycle 3 3.33 .333 0 
Exercise 31 2.55 .138 0 
Movie 37 3.11 .095 0 
Concert/Music 23 4.00 .141 1 
Ipod 26 2.87 .126 0 
Cafeteria 16 2.87 .072 0 
Play in Band 7 3.43 .414 2 
Power Tools  3 3.33 .601 0 
Hunt/Gun 5 4.50 .387 4 
Pedestrian, Plane, Boating, Construction, Industry/Factory 
Job, Farm work, Mechanic, Military service, 
Explosives/fireworks not included due to limited reported 
participation 
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Table 7-3.  Adolescent Hearing Habit (AHH) Participation and HPD Use.  This 
table provides a summary of frequency of noisy activity reported by the subjects.  
The Hearing Protection Device (HPD) use is also indicated.  Again participants 
that hunted were more likely to report use of HPD. 
 
 
Noisy Activity Never Seldom Often Always HPD 
Fireworks 3 37 0 0 0 
Hunting/Gun Use 25 12 3 0 12 
Motorcycle 31 7 1 1 1 
Lawn Mower 21 10 5 3 4 
NASCAR 35 4 1 0 2 
Rock Concert 4 20 15 1 5 
Disco/Club 8 7 18 7 2 
Aerobics Class 19 5 6 10 0 
Headphones 2 1 6 31 0 
Stereo in Home 4 12 15 9 1 
Stereo in Car 2 6 12 20 0 
Play in Band 24 4 3 9 5 
Power Tools 24 11 4 1 6 
Work 21 9 3 7 4 
 
 
In summary, the noise exposure history descriptive information revealed limited 
participation in higher noise activities such as hunting/gun use, playing in a band or 
working in a noisy environment.  The difference in reported activities between the GNH 
and AHH were related to the retrospective timeline associated with each metric.  The 
purpose of the GNH was to determine noisy activity participation on average over the 
past few weeks, while the modified AHH and NEH were used to determine lifetime of 
participation in noisy activities. 
 
Statistical Analysis 
 Spearman rho correlations were performed to determine relationships between 
descriptive variables and noise exposure.  Chi-square and ANOVA were performed to 
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compare findings for categorical and scale variables, respectively.  Data were entered into 
SPSS from Excel databases. The NEH, GNH, AHH and TNH results (see Appendix C for 
copies of the questionnaires) were compared among groups (experimental and control) 
and sexes.  The purpose of this analysis was to determine if the experimental and control 
group differed in degree of noise exposure and if differences existed between the sexes (p 
< .05).   
 
Results 
 No significant correlations were discovered regarding noise exposure and 
presence of type-1 diabetes (including NHE, GNH, and AHH variables and TNH).  This 
means that both the control and type-1 diabetes groups had similar noise exposure 
histories (see Figure 8-1 in Chapter VIII titled Sex, noise, and type-1 diabetes section).  
On the other hand, significant correlations for noise exposure were found with sex, with 
males demonstrating greater noise exposure in all instances (AHH = -.386, p < .05 and 
TNH = -.339, p < .05).  Figure 7-4 shows the mean noise exposure history for males 
compared to females.  Sex differences were significant for mean TNH (F = 4.921, p < 
.05) and AHH (F = 6.203, p < .05), but not GNH (F = 1.422, p > .05).   
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Figure 7-4.  Males versus Females Noise History.  This figure demonstrates the 
higher levels of noise exposure reported by males compared to females.  The 
AHH (far left) and TNH (far right) revealed significantly higher noise exposure in 
males, the variance in the GNH (center) was too large to demonstrate a difference.  
This supports the notion that the acute noise history metric is much more variable 
than consideration of longer- term noise exposure history.  Mean and SEM are 
shown. 
 
 
 
Experimental and control participants were subsequently rank ordered for TNH 
and separated into high and lower noise exposures groups and compared.  Figure 7-5 
shows the separation of higher and lower noise exposure based on the TNH. 
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Figure 7-5.  Total Noise Rank.  The figure depicts the frequency count for 
separation of participants into higher and lower noise exposure based on TNH 
rank.  Ties were separated on exposure to highest intensity noise sources, e.g.,  
gun/hunting. 
   
Table 7-4 summarizes the significant auditory function findings and level of noise 
exposure, p < .05, the SEM is provided in the parentheses. The primary finding was 
diminished TEOAE and DPOAE fine structure findings.  No PTA or regular DPOAE 
demonstrated significant differences, while one ABR variable was significant.  
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Table 7-4.  Higher vs. Lower Levels of Total Noise History.  This table provides 
the auditory function outcomes that demonstrated significant differences (p < .05) 
in noise exposure for higher and lower levels of THN. 
 
Auditory Measure n Lower (SEM) Higher (SEM) F-test 
TEOAE 65 dB 19.3/sec 40 5.30 (1.12) 1.83 (1.19) 4.520 
TEOAE 65 dB 2/sec 40 6.89 (.850) 3.86 (.961) 5.592 
TEOAE 80 dB 40 18.46 (.742) 16.35 (.698) 4.304 
     1500 Hz 40 -8.223 (1.11) -12.912 (1.16) 8.533 
     4000 Hz 40 -17.83 (1.09) -21.52 (.962) 6.401 
Reflection @ 35 dB, 1176 Hz 32 -11.20 (.834) -15.05 (1.54) 4.111 
Reflection @ 65 dB, 3731 Hz 32 1.71 (1.57) -.793 (1.15) 6.329 
Reflection @ 35 dB, 5920 Hz 32 -29.36 (1.34) -33.77 (1.22) 5.833 
Wave I Lat 108 dB @ 27.7 40 1.65 (.027) 1.74 (.024) 5.207 
 
 
Next, a 2 X 2 ANOVA examining the interaction of noise exposure (higher and 
lower TNH) and diabetes was performed in the auditory function measures that 
demonstrated a significant relationship to noise.  The findings are summarized in Table 7-
5. The only significant interaction for noise was seen for the L2 =35 dB SPL reflection 
component RMS at 1176 Hz, (F = 4.853, p < .05). 
 
Table 7-5. Interaction of Diabetes and TNH.  One significant interaction was 
indicated (*), but the findings for the type-1 group with higher noise exposure 
show a trend for reduced function (same n as previous table). SEM in parentheses. 
 
Auditory Measure  
Diabetes  x TNH 
Control 
Lower 
Type-1 
Lower 
Control 
Higher 
Type-1 
Higher 
TEOAE 65 dB 19.3/sec 6.15 (1.15) 4.46 (1.95) 4.08 (1.42) -.42 (1.69) 
TEOAE 65 dB 2/sec 8.13 (.844) 5.65 (1.41) 4.89 (1.42) 2.82 (1.36) 
TEOAE 80 dB 18.65 (.902) 18.27 (1.22) 17.56 (.946) 15.14 (.912) 
     1500 Hz -7.35 (1.08) -9.10 (1.97) -10.97 (1.65) -14.87 (1.46) 
     4000 Hz -19.13 (1.22) -16.53 (1.79 -20.43 (1.66) -22.61 (.939) 
Reflection @ 35 dB,1176Hz* -11.62 (1.09) -10.79 (1.33) -11.52(1.69) -19.46 (1.82)  
Reflection @ 65 dB,3731Hz -21.98 (1.93) -19.47 (1.88) -24.60 (1.99) -25.52 (1.54) 
Reflection @ 35 dB,5920Hz -28.46 (2.18) -32.5 (1.68) -30.26 (1.80) -35.35 (1.51) 
Wave I Lat 108 dB @ 27.7 1.63 (.050) 1.65 (.044) 1.72 (.039) 1.72 (.034) 
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Discussion 
In the previous sections we found significant differences in auditory function 
between type-1 diabetes and control groups limited to the most sensitive measure of 
cochlear function (DPOAE fine structure).  In addition, there was limited influence of 
diabetes related covariates on auditory function.  However, we did find an overall sex 
difference with males demonstrating poorer cochlear and afferent function.  On the other 
hand, no sex effects were seen in relationship to diabetes related variables, indicating 
similar levels of control and care. 
The noise exposure profiles demonstrated rare exposure to occupational sources 
of noise exposure.  The primary sources of noise exposure in this population were related 
to recreational and leisure activities.  However, most of these activities were only 
performed occasionally.  Activities such as bar/club attendance (75%), musical 
instrument/playing in band (60%), and concert attendance (20%) had the greatest 
frequency of weekly participation at some period in life.  However, very few participated 
in activities such as gun/hunting (2.5%) and power tools use (12.5%).   
The literature provides contradictory evidence to the influence of sporadic 
recreational noise exposure on susceptibility to hearing loss, most studies indicating a 
limited influence (Mostafaspour, 1998).  The lack of occupational noise exposure in this 
group may have limited our capacity to explore noise exposure as a variable of influence.  
In other words, the range of noise exposure may have not been large enough to 
distinguish higher levels of noise exposure with greater probability of damage from lower 
levels with diminished probability of damage.  However, we were able to show that 
participants with higher noise exposure had poorer outcomes. 
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When examining noise exposure, no significant difference in noise exposure 
histories were found between the experimental and control groups, though males did 
demonstrate significantly higher levels of noise exposure.  This creates a dilemma, since 
males have higher noise exposure and poorer auditory function it is difficult to separate 
the influence of noise exposure alone on diabetes and auditory function.  For example, 
males with higher noise exposure make up the majority of the participants in the “high 
noise” groups, since males have poorer auditory function this may artificially exacerbate 
the noise findings.  
Another limitation of the analyses alluded to already was the variability of noise 
exposure levels.  Only a minority of participants reported work related noise exposure, 
the majority of the noise exposure reported was related to recreational sources that can be 
highly variable in level, duration, and questionable in relation to pathological influence.  
There was not a large range of noise exposure with few participants reporting very high 
or very low life long levels of noise exposure; most reported moderate exposure (see 
Figure 7-2).  A solution to this limitation would be for future studies to recruit 
participants with higher levels of similar noise exposure with type-1 diabetes and 
without.  In addition, examining susceptibility to temporary threshold shift may provide 
some clues to the interaction of noise and type-1 diabetes.  
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CHAPTER VIII 
 
SEX, NOISE, AND TYPE-1 DIABETES 
 
The finding that male participants have greater noise exposure and reduced 
auditory function outcomes compared to female participants limits our ability to examine 
the interaction between noise and type-1 diabetes.  We did not have a sample size 
sufficient to examine noise groups (those with lower and higher TNH) in males and 
females separately.  This would be an appropriate next step to determine the underlying 
influences. Instead, Tables 8-1 and 8-2 provide summaries of mean responses for males 
only and females only for the auditory function measures that were shown in the previous 
chapter to be significantly related to noise exposure.  The trend of the data supports 
poorer performance in the groups Diabetes with High Noise exposure (both males and 
females) compared to Control groups (High Noise and Low Noise).  Note the sample size 
for each group. 
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Table 8-1.  Summary of Sex, Noise, and Diabetes.  This table breaks down the 
mean amplitude for OAE responses and ABR wave I latency.  Males and females 
with higher noise exposure show a trend for lower amplitude responses in 
comparison to controls and prolonged wave I latency.  The sample size for each is 
provided in parentheses. 
 
 
Auditory Measure Diabetes Low 
Noise 
Diabetes 
High Noise 
Control Low 
Noise 
Control High 
Noise 
 M (2) F (8) M (7) F (3) M (4) F (6) M (5) F (5) 
TEOAE 65 19/sec -2.04 6.08 -2.34 4.04 5.39 6.66 1.89 6.27 
TEOAE 65 2/sec 1.32 6.74 1.31 6.34 8.70 7.74 2.79 6.99 
TEOAE 1500 Hz -17.21 -7.07 -16.3 -11.6 -7.52 -7.24 -13.6 -8.8 
TEOAE 4000 Hz -25.2 -14.4 -22.7 -22.4 -20.7 -18.4 -23.3 -17.6 
Wave I Lat 108 @ 
27 
1.74 1.63 1.74 1.66 1.56 1.68 1.80 1.64 
 
 
 
Table 8-2.  Summary of Sex, Noise, and Diabetes for Fine Structure.  The table 
summarizes fine structure findings that were significant for levels of noise 
exposure.  Males with high noise and diabetes have the poorest RMS levels.  The 
sample size is provided in parentheses. 
 
 
Fine Structure Diabetes Low 
Noise 
Diabetes High 
Noise 
Control Low 
Noise 
Control High 
Noise 
 M (1) F (6) M (6) F (2) M (3) F (4) M (5) F (5) 
Reflection @ 35 
dB, 1176 Hz 
-13.42  -11.31  -21.24  -14.11  -10.77  -10.80 -12.72 -10.33  
Reflection @ 65 
dB, 3731 Hz 
-17.98  -19.72  -26.12  -27.70  -20.62  -22.99  -24.97  -24.24  
Reflection @ 35 
dB, 5920 Hz 
-30.49  -30.23  -35.17  -35.90  -30.32  -27.05  -35.73 -29.28  
 
 
To further explore this relationship we examined male control versus male 
experimental participants and female control versus female type-1 diabetes participants 
separately, excluding further separation into higher and lower noise.  Since males (both 
control and type-1) had higher noise exposure than females (both control and type-1), a 
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greater loss in the male experimental group versus the male control group may be related 
to the higher noise exposure, particularly if the female group comparison did not show 
the same finding.  The first step was to account for noise exposure to determine if the 
sex-specific controls differed from the experimental subjects.   Figure 8-1 shows the 
average TNH for males and females with type-1 diabetes compared to controls and 
separated by sex (similar findings were found for the GNH and AHH). 
0 1 2 3 4 5
Male Control
Male Type-1
Female Control
Female Type-1
TNH LEVEL  
Figure 8-1.  Sex-Specific Noise Exposure Levels.  Male controls and 
experimental participants had similar group noise exposure, as did the females, 
with males being higher and females being lower. Mean and SEM shown. 
 
 
 
 While males in general have greater noise exposure than females, male control 
and male type-1 participants did not differ significantly from each other, which holds true 
for females as well.  Table 8-3 summarizes the sex-specific comparison of the noise 
related outcome measures (from Chapter VII) and presence of diabetes; SEM are provide 
in parentheses.  The asterisk indicates a significant finding. 
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Table 8-3.  Sex-specific Comparison.  This table provides a summary of the 
findings for outcomes that were significantly related to noise.  The asterisk (*) 
indicates a significant result. (n =40 TEAOE and ABR; n=32 Fine Structure). 
 
 
Auditory Measure  M  
Control  
M 
Type-1  
F 
Control  
F 
Type-1  
TEOAE 65 dB 19.3/sec 3.45 (1.73)* -2.27 (1.51) 6.48 (.748) 5.52 (1.52) 
TEOAE 65 dB 2/sec 5.42 (1.74) 1.31 (1.15) 7.41 (.600) 6.62 (1.17) 
TEOAE 80 dB 16.77 (1.23) 14.49 (1.12) 19.19 (.442) 18.51 (.902) 
     1500 Hz -10.66 (2.05)* -16.49 (1.38) -7.92 (.825) -8.30 (1.47) 
     4000 Hz -21.95 (1.32) -23.25 (.869) -17.99 (1.31) -16.55 (1.45) 
Reflection @ 35 dB, 1176Hz  -11.9 (1.87)* -20.12 (1.92) -10.54 (1.35) -12.02 (1.08) 
Reflection @ 65 dB, 3731Hz  -.186 (1.46) -2.74 (1.74) -23.69 (1.79) -21.71 (2.08) 
Reflection @ 35 dB, 5920Hz  -33.70 (2.09) -34.5 (1.61) -11.23 (2.82) -13.36 (3.05) 
Wave I Lat 108 dB @ 27.7 1.72 (.059) 1.76 (.082) 1.68 (.034) 1.64 (.022) 
  
 
 Interestingly males, who as a group have higher noise exposure, show significant 
differences between groups, while females, with lower noise exposure as a group, do not.  
This finding suggests that the interaction of higher noise exposure in males with type-1 
diabetes may partially explain the reduced function.  On the other hand, females with 
overall lower noise exposure did not show a difference between groups.   
To clarify this question a larger sample size and greater range of noise exposure 
will be needed.  Another potential explanation is related to sex differences in regards to 
metabolic function and diabetes.  Though our type-1 group did not show differences in 
terms of control, HbA1c, or presence of diabetes related complications, some sex-specific 
(e.g., related to hormones) interaction with type-1 diabetes may exist that reduces 
cochlear function in males regardless of noise exposure history (see McFadden et al., 
2009 for a review on sex-differences and auditory function). 
In summary, the preliminary indication of noise interaction with diabetes 
demonstrated in Chapter VII may be confounded by the predominant male sex 
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comprising the high noise groups.  Separate sex-specific findings however support either 
an interaction of sex with diabetes resulting in reduced function, the type-1 diabetes 
groups showing increased risk for NRHL, or an interaction.   
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CHAPTER IX 
 
INTEGRATING DISCUSSION 
 
 While the very relationship of diabetes to hearing loss remains under debate, as 
demonstrated by the contradictory findings reviewed, as a whole, the literature supports 
an influence of diabetes on susceptibility to hearing loss. We report no difference 
between the type-1 diabetes and control groups using the common clinical methods for 
basic audiological measures, cochlear function, peripheral efferent function, and 
peripheral afferent function assessment.   
However, we did find significant differences in DPOAE fine structure measures.  
The reduced RMS amplitudes associated with the reflection component, diminished 
number of fine structures (count), and increased RMS amplitude growth was 
characteristic of changes related to early signs of cochlear pathology.  In an everyday 
clinical assessment our groups would not have demonstrated a difference in auditory 
function. Therefore, our findings also give support to the potential clinical implications of 
DPOAE fine structure and lower level TEOAEs (65 dB peak SPL) in identifying early 
signs of cochlear pathology (one of our secondary objectives of this study; see Chapter X 
Future Directions).   
 Our covariate findings revealed limited influence of age and diabetes related 
variables (duration, HbA1c, control, etc.) on auditory function.  This finding is not 
surprising given the young age of the sample (18-28 years) and the lack of reported poor 
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control or diabetes related complications (no participants reported neuropathy, 
retinopathy, or nephropathy).   
On the other hand, we did find a strong influence of sex on our outcome 
measures, primarily reduced OAE amplitudes and prolonged ABR latency and reduced 
amplitudes of wave I and V in males.  However, these sex differences have been reported 
in numerous studies.  Females generally have stronger OAEs (larger amplitudes) and 
ABRs (shorter latency and larger amplitude).  However, these differences may not reflect 
“better” auditory function, but differences in external/middle ear characteristics and 
cochlear size.  For example, McFadden et al. (2009) demonstrated that OAEs associated 
with the reflection component (TEOAE, SFOAE, SOAE) were larger, while OAEs 
primarily representative of the distortion component (DPOAE) were more similar 
between sexes.  It is plausible that length differences of the cochlea (female cochlea’s are 
8-13% shorter than males) may increase the perturbations that underlie the theoretical 
source of the reflection component. 
The most noteworthy finding related to sex was the results of the sex-specific 
analysis.  When auditory function was examined in the male experimental group versus 
the male control group, a significant difference was found in a number of the outcome 
measures, most prominently low-level TEOAEs and DPOAE fine structure.  However, 
comparable findings were not found in the female group comparison.   
The difference in sex-specific findings may be related to an interaction between 
male sex and type-1 diabetes (e.g., biochemical effect of andrognes) or potentially the 
higher noise exposure demonstrated in our male participants. Noise-related damage is 
associated with both mechanical and metabolic compromise.  Overexposure to noise can 
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alter cochlear homeostasis resulting in excessive reactive oxygen/nitrogen species, 
vascular changes, activation of apoptosis-like pathways, excitoxic events, and subsequent 
cellular damage (Henderson, 2006). Therefore, the pathological effects of noise on the 
auditory system may be exacerbated by consequences of genetic, autoimmune, and 
biochemical interactions associated with diabetes.   
Recent epidemiological findings have demonstrated poorer pure-tone thresholds 
in populations with diabetes, particularly in young adulthood, but as age increased 
threshold findings compared to controls diminished (Vaughan et al., 2005; Bainbridge et 
al., 2008; Austin et al., 2009). This reduces the likelihood of age and diabetes related 
complications underlying the earlier onset hearing loss.  Therefore we hypothesized that 
type-1 diabetes may exacerbate susceptibility to noise related hearing loss (NRHL). 
Diabetes, specifically hyperglycemia, initiates a complex cascade of biochemical 
consequences.  Three main effects are non-enzymatic glycation, activation of polyol 
pathway, and generation of reactive oxygen/nitrogen species.  Metabolic processes 
disrupted include: energy production, abnormal accumulation of metabolic by-products, 
nitric-oxide and glutathione dysregulation, glycation, lipid balance abnormalities, and 
protein synthesis dysfunction. Above all increased oxidative stress has been implicated in 
diabetes pathogenesis and co-morbidities associated with diabetes including hearing loss 
(Liu et al., 2008; Aladag et al., 2009). The cumulative effects of these biochemical 
changes may contribute to damage of blood vessels and compromised metabolic function. 
The high-energy demands of the cochlea could be disrupted by these changes, 
particularly with additional demands created by noise exposure.   
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The findings of reduced cochlear function, primarily in male participants with 
type-1 diabetes and higher noise exposure provides preliminary support to our hypothesis 
of increased risk for NRHL.  This finding is timely given the recent indications of 
increased incidence of noise-related hearing loss in adolescents 12-19 years of age 
(Shargorodsky et al., 2010). If participants with type-1 diabetes are at increased risk for 
NRHL, then stronger efforts in prevention may offset the early onset of loss found in 
epidemiological studies. 
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CHAPTER X 
 
FUTURE DIRECTIONS  
 
 The following steps are recommended for future phases of this work: 
 
1. The demonstration of early indices of reduced cochlear function is compelling 
and suggests that sex, noise, and/or the interaction of sex and noise may influence 
the early onset of hearing loss in the diabetes population reported in recent 
epidemiological studies.  In order to fully pursue this question we will need to 
increase our sample size with inclusion of more male and female participants with 
greater noise exposure histories. Therefore, a next step will be to recruit more 
age- and sex-matched participants with occupational sources of steady noise with 
our same inclusion criteria. 
 
2. The findings of this study suggest minimal neural involvement in the reduced 
function found.  Therefore, as we continue this study we will limit the auditory 
function measures to the basic audiological battery and otoacoustic emissions 
(TEOAEs, DPOAEs, and DPOAE Fine Structure).  This will also focus part of 
our effort identifying early indices of cochlear damage prior to changes in pure-
tone thresholds or even commonly used clinical OAE testing protocols (DPOAE 
fine structure and low-level TEOAEs). 
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3. Another important step will be enhancing our data analysis methodology to look 
at more fine structure features (e.g. spacing, depth, etc.) and frequency specific 
bands, similar to our 1/3 octave band RMS amplitude analysis.  Frequency band 
analysis may provide more details to location of pathology. 
 
4. A retrospective account of noise exposure is limited, particularly by participant 
recall error (overestimates and underestimates).  Moreover, a passive prospective 
account (e.g. noise diary) or daily noise exposure may not be representative of the 
participants “true” life-long noise exposure.   Therefore, in addition to the sample 
adjustments proposed in step 1, we will also seek to examine susceptibility to a 
temporary threshold shift (TTS).  A TTS experiment involves a noise exposure 
paradigm.  The participant is exposed to a sound level that will cause a temporary 
reduction in thresholds that fully recover.  By including a TTS experiment we can 
explore if persons with diabetes have exacerbated TTS compared to controls and 
monitor the progression of DPOAE fine structure changes immediately after the 
insult and as the threshold recovers. 
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APPENDIX A 
 
MECHANISMS CONTRIBUTING TO HEARING LOSS IN DIABETES 
  
The purpose of this appendix is to provide a brief review of the literature focused 
on the cellular and molecular pathophysiology of hearing loss related to diabetes.  In 
contrast to the large number of clinical and epidemiological studies of diabetes, very few 
studies have directly examined the basic pathological interaction between diabetes and 
hearing loss.  The limited understanding of the cellular and molecular pathways 
contributing to hearing loss in persons with diabetes is related to absence of a proper 
animal model of diabetes and lack of access to cochlear tissue in humans in vivo. 
Human Histological Studies. Human histological studies examining the effects of 
diabetes and auditory pathology are fairly limited.  Recently, Fukushima et al. (2005, 
2006) examined histological cochlear changes in adults with type 1 and type 2 diabetes 
and found significantly greater cochlear microangiopathy, degeneration of the stria 
vascularis, spiral ligament, and auditory outer hair cells than in age-matched controls.  No 
significant difference was seen in number of spiral ganglion cells. Subjects with a history 
of noise exposure were excluded.  The author’s interpretation was that microangiopathy 
associated with diabetes affected inner ear vasculature and caused degeneration of inner 
ear structures.  These findings suggest a primarily cochlear pathology. 
Animal Studies.  The most commonly used animal model of diabetes is the 
streptozocin-treated (STZ) rat.  Most studies of diabetes and hearing loss in animals have 
used this model (Nageris et al., 1998; Liu et al., 2008), including those examining 
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susceptibility to noise related hearing loss (Smith et al., 1995; Raynor et al., 1995; Wu et 
al., 2009).  However, the problem with this is model is that STZ itself may interfere with 
hair cell metabolism (Fowler and Jones, 1999).  A second model, the mouse strain 
SHR/N-cp is a rat that develops diabetes at 12 months of age.  This model has also been 
used in auditory function studies (Triana et al., 1991), including noise (McQueen et al., 
1999).  However, cochlear pathology in the model was demonstrated at 5 months of age, 
which was 7 months prior to the animal becoming “diabetic”.  Therefore, the cause may 
represent a genetic mutation rather than direct effect of diabetes itself.  A third model, the 
NOD strain of mice has also been used to study auditory function, in particular 
autoimmune effects (Nakae and Tachibana, 1986; Ohlemiller et al., 2008; Vasilyeva et 
al., 2009).   
Vasilyeva et al. (2009) examined the interaction of age and diabetes in two animal 
models, one representative for type-1 diabetes (STZ) and a second representative of type-
2 diabetes (dietary induced).  The results demonstrated reduced auditory function in both 
models, but the ABR thresholds and wave I amplitudes were only significantly altered in 
the type-2 model.   
No animal model of diabetes is perfect and much work is needed in understanding 
the cellular and molecular influences of diabetes on susceptibility to hearing loss. The 
primary pathological findings in these studies examining “diabetic” animals are outer hair 
cell loss (with mostly preserved inner hair cells), pathological changes of the stria 
vascularis, reduced endocochlear potential (battery that drives cochlea involving k+ 
recycling involving the stria vascularis), and minimal changes in primary afferent 
auditory nerve fibers.  
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Genetic Influence. The genetic relationship between hearing loss and diabetes is 
complex and inclusive of direct, indirect, and environmental influences. Specific genetic 
mutations affecting nuclear and mitochondrial genes in both syndromic and non-
syndromic manifestations have been related to hearing loss and diabetes (Diniz et al., 
2009).  These include Wolfram Syndrome, maternally inherited diabetes and deafness 
(MIDD), and myoclonic epilepsy, lactic acidosis, and stroke-like episodes (MELAS) 
(Kokotas et al., 2007).   
Autoimmune Associations.  Autoimmune factors have been associated with both 
diabetes and hearing loss.  However, the precise interaction of autoimmune disease, 
diabetes, and hearing loss has been elusive.  In NOD mice-models of autoimmune effects, 
the main implications are believed related to strial pathology.  In the case of type-1 
diabetes, primary damage involves inflammatory infiltration and destruction of organs 
and connective tissue.  By contrast, cochlear pathology in these mice does not show 
inflammation, but instead immunoglobulins that bind to endothelial cells and capillary 
basement membranes (Ohlemiller et al., 2008).    
Biochemical Hypotheses. Wang and Schacht (1990) examined the role of insulin 
in the inner ear of the guinea pig. They reported a lack of an effect of insulin on glucose 
metabolism in the cochlea, but the hormone did increase protein synthesis and lipid 
metabolism.  They proposed a phospholipid-based transmembrane signaling system 
mediating the effects of insulin on the inner ear.   
Diabetes, specifically hyperglycemia, initiates a complex cascade of biochemical 
consequences.  Three main effects are non-enzymatic glycation, activation of the polyol 
pathway, and generation of reactive oxygen/nitrogen species.  Metabolic processes 
 107 
disrupted include: energy production, abnormal accumulation of metabolic by-products, 
nitric-oxide and glutathione dysregulation, glycation (advanced glycation end products), 
lipid balance abnormalities, and protein synthesis dysfunction.  Tissue damage associated 
with diabetes includes: endothelial, neural, extracellular, and collagen compromise 
(Frisina et al., 2006). Up-regulation of vascular endothelial growth factor (VEGF) and 
nitric oxide isoforms have been demonstrated in the cochlea of diabetic rats (Liu et al., 
2008).  
Increased oxidative stress also has been implicated in diabetes pathogenesis and 
co-morbidities associated with diabetes including hearing loss (Liu et al., 2008; Aladag et 
al., 2009).  Attempts have been made to correlate oxidative stress with glycated 
hemoglobin (HbA1c) (Choi et al., 2008; Goodarzi et al., 2008). The cumulative effects of 
these biochemical changes contribute to damaged blood vessels and compromised 
metabolic function. The high-energy demands of the cochlea could be disrupted by these 
changes, particularly with additional demands created by noise exposure.   
Noise and Diabetes Interaction.  The effects of noise exposure alone on hearing 
are well documented.  Noise-induced damage is related to both mechanical and metabolic 
compromise.  Overexposure to noise can alter cochlear homeostasis resulting in excessive 
reactive oxygen/nitrogen species, vascular changes (an initial ischemia followed by 
reprefusion), activation of apoptosis-like pathways (e.g. Bcl-2 family), excitotoxic events 
(excessive glutamate), and subsequent cellular damage (Henderson, 2006). The 
pathological effects of noise on the auditory system may be exacerbated by the 
consequences of genetic, autoimmune, and biochemical interactions associated with 
diabetes discussed above.   
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Controlled animal experiments have demonstrated a more significant loss of outer 
hair cells (OHCs) in noise exposed rats with diabetes (STZ injected) compared to noise 
exposed controls but without consideration of molecular mechanisms and relationship to 
glucose metabolism (Smith et al., 1995 and Raynor et al., 1995).  McQueen et al. found 
significant basement membrane thickening of the cochlea (microangiopathy) in rats 
(SHR/N-cp) with NIDDM, however only in the combination with obesity and/or 
exposure to noise.  Wu et al. (2009) found that rats (STZ injected) with diabetes 
demonstrated impaired recovery from a noise induced temporary threshold shift, this 
recovery was improved to control levels with insulin treatment. 
Summary.  The relationship between diabetes and hearing loss has been debated 
for over a century.  Study methodology limitations and differences have led to highly 
variable findings.  Prominent examples are the interaction between age and diabetes, lack 
of consideration for type of diabetes, and minimal account for control or severity of 
diabetes.  The cumulative effects of diabetes contribute to damaged blood vessels and 
compromised metabolic function.  The high-energy demands of the cochlea could be 
disrupted by these changes, particularly with additional demands created by noise 
exposure. Human studies of diabetes generally have excluded individuals with a history 
of noise exposure or ignored the potential interaction between noise and diabetes on 
hearing status.  This hypothesized interaction may leave diabetics with high levels of 
noise-exposure at exacerbated risk for noise-related hearing loss.  
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APPENDIX B 
 
 
 
Mean and SEM for non-significant data are provided for outcomes comparing 
control and experimental groups not presented in a table or figure in the manuscript.  The 
order of the presentation of tables follows the outline of the dissertation manuscript.   
 
 
 
Pure Tone Threshold Average PTALOW PTAHI PTAE 
Mean 4.6250 3.9750 -.1875 
N 20 20 20 
Control 
SEM .66775 .63606 2.00026 
Mean 6.3250 4.4750 2.8437 
N 20 20 20 
Type-1 
SEM .70736 .64018 2.23030 
Mean 5.4750 4.2250 1.3281 
N 40 40 40 
Total 
SEM .49902 .44720 1.49839 
 
 
 
 
TEOAE 
Amplitudes TEOAE 
TEOAE 
1000 Hz 
TEOAE 
1500 Hz 
TEOAE 
2000 HZ 
TEOAE  
3000 HZ 
TEOAE 
4000 HZ 
Mean 18.1023 -5.6187 -9.1578 -15.7225 -18.0443 -19.7765 
N 20 20 20 20 20 20 
Control 
SEM .64795 .88726 1.04506 .80858 1.43670 1.01532 
Mean 16.7040 -8.1460 -11.9843 -17.5355 -18.9647 -19.5660 
N 20 20 20 20 20 20 
Type-1 
SEM .82794 1.12253 1.36437 1.42884 1.16735 1.20555 
Mean 17.4031 -6.8824 -10.5710 -16.6290 -18.5045 -19.6713 
N 40 40 40 40 40 40 
Total 
SEM .53083 .73461 .87789 .82319 .91661 .77808 
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TEOAE Noise  
TEOAE 
TEOAE 
1000 Hz 
TEOAE 
1500 Hz 
TEOAE 
2000 Hz 
TEOAE 
3000 Hz 
TEOAE 
4000 Hz 
Mean 6.9980 -20.6380 -25.0965 -30.9535 -34.3740 -29.5015 
N 20 20 20 20 20 20 
Control 
SEM .79665 .66678 .87658 .46714 1.78879 .26019 
Mean 8.5385 -19.1790 -24.0310 -30.5780 -35.9840 -29.5245 
N 20 20 20 20 20 20 
Type-1 
SEM .94376 .87662 .85344 .53922 .87213 .57903 
Mean 7.7683 -19.9085 -24.5637 -30.7657 -35.1790 -29.5130 
N 40 40 40 40 40 40 
Total 
SEM .62191 .55600 .60981 .35339 .99062 .31331 
 	  	  	  
 
TEOAE at 65 dB Slow rate Fast rate 
Mean 6.510675 5.1153 
N 20 20 
Control 
SEM .8556498 .92081 
Mean 4.235825 2.0172 
N 20 20 
Type-1 
SEM 1.0103217 1.37498 
Mean 5.373250 3.5663 
N 40 40 
Total 
SEM .6783494 .85357 	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DPOAE Amp 1 dp436 dp498 dp592 dp701 dp841 dp997 dp1119 dp1401 dp1666 
Mean 4.775 7.575 9.950 12.07 13.025 13.00 10.975 9.1750 7.3250 
N 20 20 20 20 20 20 20 20 20 
Control 
SEM .9586 .8015 .9759 .9755 .92656 .9514 1.0640 1.0041 .67986 
Mean 4.525 6.100 7.575 9.150 11.500 10.35 8.5500 7.8750 7.5250 
N 20 20 20 20 20 20 20 20 20 
Type-1 
SEM .8851 1.142 1.203 1.473 1.0606 .9529 1.1007 1.0716 1.09152 
Mean 4.650 6.837 8.762 10.61 12.262 11.67 9.7625 8.5250 7.4250 
N 40 40 40 40 40 40 40 40 40 
Total 
SEM .6443 .6989 .7881 .9032 .70574 .6976 .78016 .73226 .63487 
 
 
 	  
 
 
DPOAE Amp 2 dp1977 dp2382 dp2834 dp3379 dp4002 dp4749 dp5636 
Mean 5.2250 2.3750 2.3500 7.8000 5.6750 2.3250 -1.6250 
N 20 20 20 20 20 20 20 
Control 
SEM .99173 .90820 1.56319 1.67897 2.42717 1.84044 1.48894 
Mean 5.1750 2.7000 1.5250 5.4000 3.5000 -1.9000 -4.0250 
N 20 20 20 20 20 20 20 
Type-1 
SEM 1.03826 1.16269 1.55152 1.82259 1.93479 1.91414 1.33696 
Mean 5.2000 2.5375 1.9375 6.6000 4.5875 .2125 -2.8250 
N 40 40 40 40 40 40 40 
Total 
SEM .70865 .72862 1.08902 1.23805 1.54182 1.35352 1.00616 
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DPOAE Noise1 dp436 dp498 dp592 dp701 dp841 dp997 dp1199 dp1401 dp1666 
Mean -2.85 -3.95 -6.55 -7.50 -11.20 -9.85 -12.85 -15.50 -15.80 
N 20 20 20 20 20 20 20 20 20 
Control 
SEM .982 .961 .809 .587 .647 .802 .525 .763 .579 
Mean -2.15 -2.75 -5.65 -7.30 -9.45 -11.00 -11.80 -14.65 -16.65 
N 20 20 20 20 20 20 20 20 20 
Type-1 
SEM 1.173 1.289 .765 .798 .716 .775 .942 .689 .604 
Mean -2.50 -3.35 -6.10 -7.40 -10.33 -10.43 -12.33 -15.08 -16.23 
N 40 40 40 40 40 40 40 40 40 
Total 
SEM .757 .799 .554 .489 .497 .558 .539 .512 .418 
 
 
 
 
 
 
DPOAE Noise 2 dp1977 dp2382 dp2834 dp3379 dp4002 dp4749 dp5636 
Mean -19.75 -23.50 -24.10 -22.90 -18.35 -15.85 -12.55 
N 20 20 20 20 20 20 20 
Control 
SEM .593 .587 .688 .571 .704 .744 .727 
Mean -19.45 -23.85 -25.00 -23.05 -18.40 -14.30 -11.15 
N 20 20 20 20 20 20 20 
Type-1 
SEM .647 .708 .661 1.053 .400 .543 .838 
Mean -19.60 -23.68 -24.55 -22.98 -18.38 -15.07 -11.85 
N 40 40 40 40 40 40 40 
Total 
SEM .434 .455 .476 .591 .400 .471 .559 
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OAE Suppression 
CCX and Suppression BISUP 
BISUP 
CXX COSUP 
COSUP 
CCX 
Mean 3.8325 .87250 1.02188 .93450 
N 8 8 8 8 
Control 
SEM .50977 .029092 .274670 .017486 
Mean 3.6236 .73850 1.12112 .88250 
N 8 8 8 8 
Type-1 
SEM .44821 .043177 .048089 .023418 
Mean 3.7281 .80550 1.07150 .90850 
N 16 16 16 16 
Total 
SEM .32899 .030524 .135305 .015632 
 
 
 
 
 
 
 
 
 
OAE Suppression 
Amp and Noise 
AVGWO
Amp 
AVGWO 
Noise 
AVGBI
Amp 
AVBBI 
Noise 
AVGCO
Amp 
AVGCO 
Noise 
Mean 8.51863 -2.49800 4.68613 -1.2691 7.49675 -1.2784 
N 8 8 8 8 8 8 
No 
SEM .984360 .607449 1.07970 .975240 .976926 .96120 
Mean 7.12275 -1.45837 3.49900 .55500 6.00150 -.3245 
N 8 8 8 8 8 8 
Yes 
SEM 1.47100 .986714 1.28710 1.24589 1.45433 .94501 
Mean 7.82069 -1.97819 4.09256 -.35706 6.74912 -.8014 
N 16 16 16 16 16 16 
Total 
SEM .873766 .575575 .825861 .799731 .868027 .66266 
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ABR Amplitude I10827 V10827 I9327 V9327 V7827 I10877 V10877 V9377 V7877 
Mean .2950 .4248 .1177 .3143 .2918 .1797 .4039 .3407 .3103 
N 20 20 11 19 19 17 18 18 18 
Control 
SEM .01902 .03528 .0108 .02258 .02388 .03593 .02125 .0185 .02748 
Mean .3024 .4224 .1457 .3459 .3223 .1805 .4028 .3271 .3020 
N 20 20 11 20 20 16 20 20 20 
Type-1 
SEM .02610 .03175 .0210
2 
.02118 .01927 .02143 .02470 .0209 .02038 
Mean .2987 .4236 .1317 .3305 .3074 .1801 .4033 .3336 .3059 
N 40 40 22 39 39 33 38 38 38 
Total 
SEM .01595 .02343 .0119 .01546 .01526 .02090 .01623 .0139 .01665 
 
 
 
 
 
 
 
 
 
 
 
ABR Latency I10827 V10827 I9327 V9327 V7827 I10877 V10877 V9377 V7877 
Mean 1.6958 5.8365 2.129 6.1874 6.7650 1.8203 6.2853 6.7296 7.2779 
N 20 20 11 19 19 17 18 18 18 
Control 
SEM .03212 .05534 .1122 .05728 .08103 .07954 .06209 .07084 .08672 
Mean 1.6954 5.8604 2.062 6.3103 6.8665 1.7656 6.2501 6.7619 7.3715 
N 20 20 11 20 20 16 20 20 20 
Type-1 
SEM .02184 .04398 .1051 .05443 .09434 .03047 .05667 .07496 .09250 
Mean 1.6956 5.8484 2.095 6.2504 6.8171 1.7938 6.2668 6.7466 7.3272 
N 40 40 22 39 39 33 38 38 38 
Total 
SEM .01917 .03494 .0754 .04020 .06217 .04317 .04142 .05116 .06331 
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Spearman rho Correlations of Diabetes Control and Auditory Function 
PTA Averages Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient -.087 -.187 
Sig. (2-tailed) .715 .443 
PTALOW 
N 20 19 
Correlation Coefficient -.261 -.600** 
Sig. (2-tailed) .266 .007 
PTAHI 
N 20 19 
Correlation Coefficient -.113 -.073 
Sig. (2-tailed) .635 .766 
PTAE 
N 20 19 
 
Note: the one significant finding for high PTA (2000-8000 Hz).  The direction of the 
relationship shows poorer hearing with better control, the relationship was loss with 
consideration of total control.  This finding is probably a chance finding due to the 
overall well controlled diabetes among our sample. 
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TEOAE Amplitude Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient -.173 -.178 
Sig. (2-tailed) .465 .466 
TEOAE 
N 20 19 
Correlation Coefficient -.087 -.082 
Sig. (2-tailed) .716 .740 
TEOAE  
1000 Hz 
N 20 19 
Correlation Coefficient -.009 -.107 
Sig. (2-tailed) .971 .664 
TEOAE 
1500 Hz 
N 20 19 
Correlation Coefficient .035 .097 
Sig. (2-tailed) .885 .692 
TEOAE 
2000 Hz 
N 20 19 
Correlation Coefficient -.416 -.345 
Sig. (2-tailed) .068 .148 
TEOAE 
3000 Hz 
N 20 19 
Correlation Coefficient -.295 -.156 
Sig. (2-tailed) .207 .523 
TEOAE 
4000 Hz 
N 20 19 
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DPOAE Amplitude 1 Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient .009 .220 
Sig. (2-tailed) .971 .364 
dp436 
N 20 19 
Correlation Coefficient -.148 -.101 
Sig. (2-tailed) .535 .681 
dp498 
N 20 19 
Correlation Coefficient -.227 -.293 
Sig. (2-tailed) .336 .224 
dp592 
N 20 19 
Correlation Coefficient -.035 -.177 
Sig. (2-tailed) .884 .469 
dp701 
N 20 19 
Correlation Coefficient .035 -.229 
Sig. (2-tailed) .884 .345 
dp841 
N 20 19 
Correlation Coefficient .061 -.049 
Sig. (2-tailed) .799 .843 
dp997 
N 20 19 
Correlation Coefficient .139 .161 
Sig. (2-tailed) .558 .511 
dp1199 
N 20 19 
Correlation Coefficient .017 -.087 
Sig. (2-tailed) .942 .723 
dp1401 
N 20 19 
Correlation Coefficient .044 .011 
Sig. (2-tailed) .855 .964 
dp1666 
N 20 19 
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DPOAE Amplitude 2 Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient .052 .317 
Sig. (2-tailed) .827 .186 
dp1977 
N 20 19 
Correlation Coefficient -.096 .260 
Sig. (2-tailed) .688 .283 
dp2382 
N 20 19 
Correlation Coefficient -.130 .203 
Sig. (2-tailed) .584 .404 
dp2834 
N 20 19 
Correlation Coefficient -.087 .158 
Sig. (2-tailed) .716 .518 
dp3379 
N 20 19 
Correlation Coefficient .087 .290 
Sig. (2-tailed) .716 .229 
dp4002 
N 20 19 
Correlation Coefficient .052 .030 
Sig. (2-tailed) .827 .903 
dp4749 
N 20 19 
Correlation Coefficient -.235 -.190 
Sig. (2-tailed) .319 .435 
dp5636 
N 20 19 
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ABR Latency Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient .087 -.270 
Sig. (2-tailed) .716 .263 
I10827 
N 20 19 
Correlation Coefficient .113 -.268 
Sig. (2-tailed) .636 .267 
V10827 
N 20 19 
Correlation Coefficient .520 .261 
Sig. (2-tailed) .101 .467 
I9327 
N 11 10 
Correlation Coefficient -.052 -.149 
Sig. (2-tailed) .828 .542 
V9327 
N 20 19 
Correlation Coefficient .139 -.147 
Sig. (2-tailed) .560 .547 
V7827 
N 20 19 
Correlation Coefficient .054 -.346 
Sig. (2-tailed) .842 .206 
I10877 
N 16 15 
Correlation Coefficient .295 -.133 
Sig. (2-tailed) .207 .586 
V10877 
N 20 19 
Correlation Coefficient .104 .011 
Sig. (2-tailed) .662 .963 
V9377 
N 20 19 
Correlation Coefficient .191 -.046 
Sig. (2-tailed) .420 .853 
V7877 
N 20 19 
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ABR Amplitude Control HbA1c 
Correlation Coefficient 1.000 .674** 
Sig. (2-tailed) . .002 
Control 
N 20 19 
Correlation Coefficient .674** 1.000 
Sig. (2-tailed) .002 . 
HbA1c 
N 19 19 
Correlation Coefficient -.087 .339 
Sig. (2-tailed) .716 .156 
I10827 
N 20 19 
Correlation Coefficient .026 .314 
Sig. (2-tailed) .913 .191 
V10827 
N 20 19 
Correlation Coefficient .000 .236 
Sig. (2-tailed) 1.000 .511 
I9327 
N 11 10 
Correlation Coefficient .243 .465 
Sig. (2-tailed) .302 .055 
V9327 
N 20 19 
Correlation Coefficient .295 .509 
Sig. (2-tailed) .207 .051 
V7827 
N 20 19 
Correlation Coefficient -.027 .511 
Sig. (2-tailed) .921 .052 
I10877 
N 16 15 
Correlation Coefficient .035 .312 
Sig. (2-tailed) .885 .193 
V10877 
N 20 19 
Correlation Coefficient .252 .323 
Sig. (2-tailed) .285 .177 
V9377 
N 20 19 
Correlation Coefficient .122 .380 
Sig. (2-tailed) .609 .109 
S
p
e
a
r
m
a
n
'
s
 
r
h
o 
V7877 
N 20 19 
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APPENDIX C 
 
Demographics 
 
1.   Male   Female 
 
2.   White, Non-Hispanic   Hispanic, Latino, Mexican  
      Asian     Black, African-American 
      Pacific Islander    Native American 
      Other (specify) 
 
 
 
3. Date of Birth  (month, day, year)  age 
 
4. What is your approximate weight (lb)?   
 
5. What is your approximate height (in)?  
 
6. What is your current school grade?  
 
7. Where do you attend school?   
 Public   Private   Home 
 
8. What is the highest level of school either or your parents/guardians 
have completed?  Elementary or grade school  High School 
    Some College or university  Associate Degree 
    Bachelor’s Degree    Master’s Degree 
    Professional or Doctorate Degree 
 
9. How would you consider your family’s socioeconomic status? 
  Above Average     Average     Below Average  
 
10.  Do you have a job?  Yes   No; more than one  Yes  No 
 If yes: What type of job? (e.g. waitress)    
 How many hours do you work per week?    
 How often are you exposed to high noise at work?  High noise 
meaning louder than a noisy restaurant or loud enough that you have 
to raise your voice to talk to someone 3 feet or less away. 
  Never or almost never   Less  than half the time  Half time 
  More than half the time  Always or almost always 
If yes please fill out a work section for each job individually 
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General Noise History 
1. Please mark into the table how many days per week and how many hours per day you 
participate in these noisy activities on an average week and for how many years.  If less than 1 hr 
fill in approximate minutes per day with an “m” after, e.g. 30 m.  Also estimate the loudness where 
1 = quiet, like an empty room; 2 = somewhat quiet, can hear clearly over sound without 
need for people to raise voice; 3 = noticeable; sound of activity is loud enough to be 
distracting and difficult to understand others without raising voice; 4 = loud; can barely 
hear others even with voice raised; 5 = very loud; at the point where cannot hear others at 
all and may start to be painful.  SEE NOISE THERMOMETER FOR REFERNCE.  HPD = 
Hearing Protection Device.  PLD = personal listening device.  Indicate if you wore a PLD or HPDs 
while performing any of the activities (Y or N). 
Noisy Activity Day
/wk 
Hr/
Day 
Yrs Loudness PLD HPD 
 
     1 2 3 4 5   TV/Stereo/vid.game	             Home	  care	  	             Lawn	  care	  	             Home	  Life	   Phone	  conversation	             Car	  (drive/ride)	             Pedestrian	  busy	  traffic	             Bus,	  Subway	             Plane	             Motorcycle,	  4	  wheeler,	  dirt	  bike,	  motorsport	             Exercise	  Workout	             
	  Travel/	  
Recreation	  
Boating	             Movie,	  theatre,	  restaurant,	  bar	             Outing/	  	  
Event	  	   Concert,	  Fair,	  Party,	  Sporting	  Event	             
PLD	  w/phones	  	   	  Ipod,	  portable	  game	             Classroom	  	             Cafeteria	             Gymnasium	             Play	  in	  Band	  or	  Music	  Instrument	             Sport	  Practice/game	             Use	  power	  tools	  	             Construction	  job	             Industry/Factory	  job	             Farm	  work	             Mechanic	             
School,	  Job,	  
and	  Music	  
Military	  service	             Hunting,	  gun	  range	             Explosives/fireworks	             Other	  Noisy	   Write	  in:	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2. How often do others ask you to turn down your PLD/TV/Stereo 
volume? 
 Never  Rarely  Sometimes  Often  All the time 
 
3. Compared to your peers rate your PLD/TV/Stereo loudness 
settings? 
 Much Lower  Little lower  Same  Little higher  
 Much higher 
 
4.  Do you own an ipod, mp3 player, or other PLD? 
 Yes   No  If no skip to question 9 
 
5. How much do you use your ipod, mp3 player, or other PLD during 
a typical week? 
 0-1 hr/wk   2-4 hr/wk   5-8 hr/wk   9-15 hr/wk   >15 hr/wk 
 
6. How long have you owned a PLD type device? 
 < 6 months   > 6 months to < 1 yr   > 1 yr to < 3 yrs   
 > 3 yr to < 5 yr   > 5 yr 
 
7. The following bars represent volume levels on a PLD.  Fill in what 
best represents the volume at which you usually listen to your music 
in quiet?                                    ↓ (mid) 
 (max) 
 
8. The following bars represent volume levels on a PLD.  Fill in what 
best represents the volume at which you usually listen to your music 
in noise ( e.g. like on a bus)?                  
                                                  ↓ (mid) 
 (max) 
 
9.  Do you have continuous tinnitus (buzzing or ringing) in your ears 
almost all the time? 
 Yes  No 
 
10.  How often have you noticed a change in you hearing/ears 
(muffled, blocked, ringing, pain) when you have been exposed to 
noise/loud sounds? 
 Never  Rarely  Sometimes  Often  Always 
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11.  In what noise sources have you noticed changes to your hearing 
and or experienced tinnitus? 
 None       School    Work    Home     Movie   Concert   
 PLD        Bar/Club/Restaurant     Other (specify) 
 
 
 
12. What percentage of time are you exposed to the 5 noise levels 
(Q1 and NOISE THERMOMETER) on an average week day/night 
(total should = 100%)? 
1  2  3  4  5  
 
13. What percentage of time are you exposed to the 5 noise levels 
(Q1 and NOISE THERMOMETER) on an average weekend day/night 
(total should = 100%)? 
1  2  3  4  5  
 
14.  Have you ever done any of the following types of work or 
activities on a regular basis (weekly)?  Check all that apply 
 Musician  Carpentry/woodwork  Metal work            
 Chainsaw  Other power tools   Motorsports 
 Concerts  Club/Bar/Restaurant  Gun/Hunt/Explosive 
 Construction  Factory/Industry   Mechanic 
 
15.  What is your personal noisy activity? 
 Very low, almost none   Low, rarely   Moderate, sometimes 
 High, often   Very high, all the time 
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Work Related Noise Exposure 
 
1. What best fits your job description from question 9?  
 Bar/Restaurant/Club  Movie Theatre  Retail  
 Musician  Construction   Lawn Service            
 Mechanic  Farm  Military  Other (specify)
 
 
 
2. How many hrs per week do you work this job?  
 
3. On a scale of 1-5, what is the usual level of your work 
environment? SEE NOISE THERMOMETER FOR REFERNCE 
 1= quiet, like an empty room  2 =somewhat quiet, can hear clearly over 
sound without need for people to raise voice  3= noticeable; sound of 
activity is loud enough to be distracting and difficult to understand others without 
raising voice   4= loud; can barely hear others even with voice raised         
 5=very loud; at the point where cannot hear others at all and may start to be 
painful.   
 
4. How variable is the noise level? 
 Always variable  Usually variable    Usually steady                                      
 Completely steady 
 
5. What percentage of time are you exposed to the 5 noise levels (Q2 
and NOISE THERMOMETER) at work (total should = 100%)? 
1  2  3  4  5  
 
6.  Some noises, like a nail gun, are very loud but short in time, how 
often are you exposed to these kinds of sounds at work? 
 Never  Rarely  Sometimes  Often  Always 
 
7. How often do you use hearing protection at this job? 
 Never  Rarely  Sometimes  Often  Always 
 
8.  Have you ever received hearing conservation training? 
 Yes  No  Not sure 
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AHH	   How often do you participate in this 
activity? 
How often do you wear 
ear protection when 
doing this activity? 	   Never	   Seldom	  
	  
Sometimes	  	   Often	  	  
	  
	  
Never Sometimes	   Always	  
use	  fireworks	  
	  
	   	   	   	   	   	   	  
target	  practice	  or	  
hunting	  with	  
firearms	  
	   	   	   	   	   	   	  
ride	  a	  moped	  or	  
motorcycle	  
	   	   	   	   	   	   	  
use	  a	  power	  lawn	  
mower	  
	   	   	   	   	   	   	  
participate	  or	  
attend	  NASCAR,	  
speedway	  or	  drag	  
racing	  events	  
	   	   	   	   	   	   	  
attend	  rock	  
concerts	  
	   	   	   	   	   	   	  
attend	  discos	  or	  
dances	  
	   	   	   	   	   	   	  
attend	  aerobic	  
classes	  
	   	   	   	   	   	   	  
listen	  to	  music	  
under	  headphones	  
	   	   	   	   	   	   	  
listen	  to	  music	  
from	  your	  home	  
stereo	  system	  at	  
loud	  levels	  
	   	   	   	   	   	   	  
listen	  to	  music	  
from	  your	  car	  
stereo	  system	  at	  
loud	  levels	  
	   	   	   	   	   	   	  
play	  in	  a	  
band/orchestra	  
	   	   	   	   	   	   	  
use	  noisy	  tools	  or	  
machines	  
	   	   	   	   	   	   	  
work	  in	  a	  noisy	  
environment	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Otologic/Medical History 
 
Hearing History 
 
1. Do you have or feel you have a hearing loss? 
 Yes  No  Not sure 
 If no skip to question 8 
 
2. Which ear? 
 Right  Left  Both 
 
3. Is one ear better than the other? 
 Right  Left  Same 
 
4. How long have you had a hearing problem? 
 < 1 year  1-5 years   6-10 years  > 10 years  
 
5. Do you know what caused it? Check all that apply 
 Since birth  Related to a disease or syndrome  Noise 
 Medication  Injury or Accident  other (specify) 
 
 
 
6. Has this hearing loss been confirmed by a doctor or audiologist? 
 Yes  No  Not sure 
 
7. What type of hearing loss is it? 
 Sensorineural (inner ear)   Conductive (external/middle) 
 Mixed (both) 
 
8. Have you ever had an ear infection? 
 Yes  No  Not sure 
When was the last?  
How many total?  
Did you have tubes?  when?  
 
9. Have you ever had an ear surgery other than tubes? 
 Yes  No  Not sure 
 
10. Have you ever had balance /dizziness problems? 
 Yes  No  Not sure;  if yes describe  
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11.  Have you ever had an ear injury (trauma)? 
 Yes  No  Not sure 
 
12.  Have you ever had a head injury that affected hearing? 
 Yes  No  Not sure 
 
13.  Do you regularly take aspirin? 
 Yes  No  Not sure 
 
14.  Have you ever had any IV antibiotics? 
 Yes  No  Not sure 
 
15.  Have you ever taken any chemotherapeutic agent? 
 Yes  No  Not sure 
 
16. Have you taken an anti-malarial drug? 
 Yes  No  Not sure 
 
17. Have you taken any diuretics? 
 Yes  No  Not sure 
 
18. Do you currently or in the past smoke cigarettes, cigars, other? 
 Yes  No  Not sure 
 
19. Does someone in your household smoke or smoked while you 
were growing up? 
 Yes  No  Not sure 
 
20.  Do you currently or in your past consumed alcohol? 
 Yes        No          Not sure, if yes how often a month_______ 
 
21. Does anyone in your family have a hearing loss other than from 
getting older?  Yes  No  Not sure 
a.  Relationship 
 
 b. cause  c. age of onset 
 birth   
 child  adult   d. how much loss  little   lot   deaf 
b.  Relationship  b. cause  c. age of onset 
 birth   
 child  adult   d. how much loss  little   lot   deaf 
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22. Have you ever had speech/language issues requiring 
intervention? 
 Yes  No  Not sure 
 
23. Have you ever been told by a doctor you have any of the 
following illnesses? Check all that apply 
 kidney disease  meningitis  mumps   
 measles   chicken pox  tonsillitis 
 hyperbillirubinemia  autoimmune  HIV/AIDS 
 shingles   diphtheria  rheumatic fever 
 polio    scarlet fever  pneumonia 
 high cholesterol  heart disease  hypertension 
 Meniere’s disease  otosclerosis  epilepsy 
 mastoiditis   cancer   Crohn’s disease 
 Cushing Syndrome  cystic fibrosis  obesity/overweight 
 pancreatitis   retinopathy  lupus             
 colitis    stroke/cva  neuropathy          
 diabetes (fill out diabetes section)   mononucleosis 
 Other (specify)
 
 
 
24. Please list your current medications? 
 
 
 
 
25. Is there any other history related to health and hearing that we 
should know about? 
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Diabetes History 
 
1. What type of diabetes do you have? 
 Type 1 (IDDM)  Type 1A  Type 1B Type 2 
 MODY    Secondary  Other (specify)
 
  
 
2. Age and year you were diagnosed?    
 
3. Who made the diagnosis?  
 
4. Were any genetic tests performed? 
 Yes  No  Not sure  
If yes what test and result 
 
 
5. What type of insulin do you currently use and the dose? Type 
    Dose   
 
6. How do you currently treat your diabetes? 
 shots/pen  pump  diet  exercise 
 other (specify)  
 
7. How often do you take insulin each day on average? 
 1x a day  2 x a day  3 x a day  4 or more   
 insulin pump 
 
8. Do you often miss your meds or insulin? 
 Never           1-3 x a month   1-3 x a week  daily  
 
9. Have you ever had episodes of ketoacidosis? 
 Yes  No  Not sure;      if yes how often, when last 
   
 
10. Have you ever had severe hypoglycemia that required help? 
  Yes  No  Not sure;      if yes how often, when last 
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11. Have you been hospitalized in the past year for diabetes related 
complications? 
 Yes  No  Not sure;      if yes how often, when last 
 
  
 
12. How would your doctor rate your diabetes control? 
 excellent  good  fair  needs much work 
 
13. Has your diabetes control ever been poor?  
 Yes   No, if yes when _______ and how long________ 
 
14. How often do you test your blood sugar? 
 less than 1 x wk  less than 1 x day   1-2 x a day 
 3 x a day   4 or more  x day  only when sick 
 never 
 
15. Have you ever had the following related to your diabetes? 
 high bp   high cholesterol or fat  Addison disease 
 kidney disease  celiac disease  Hyper thyroid 
 Hypo thyroid   damaged retina/vision  neuropathy  
 Cardiovascular disease  coma     Rheumatoid Arthritis 
 obesity/overweight  abdominal pain  Other specify  
 Colitis   Chron’s Disease 
 
16. Does anyone else in your family have diabetes? 
 Yes  No;    if yes, who  
 
17. Please list the dates and levels of your most recent blood 
sugar/glycated hemoglobin tests. 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
Test___________ Date____________ Level_____________ 
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Lifestyle 
 
1.  How often over the past 7 days did you exercise or participate in 
physical activity for at least 20 minutes that made you sweat or 
breathe hard? 
 
 
 
2. How often over the past 7 days did you participate in a physical 
activity for at least 20 min that did not make you sweat and breathe 
hard?  
 
3. During the past 12 months how many team sports did you play? 
 
 
4. How much time do you watch tv during an average weekday? hrs 
 average weekend day? hrs  
 
5. How much time do you spend on the computer or playing video 
games during an average weekday? hrs  weekend day? hrs 
 
 
6. How would you consider your diet? 
 very healthy  healthy  somewhat healthy  unhealthy  
 
7. How often do you eat fast food or junk food? 
 < 1 x week   2-3 x week  almost every day  several 
times a day 
 
8.  How often do you eat vegetables and fruit? 
 < 1 x week   2-3 x week  almost every day  several 
times a day 
 
 
 
